As an innovative wealth management tool, insurance trust is gradually showing its huge market potential. China Foreign Economic and Trade Trust Co., Ltd. (hereinafter referred to as "Foreign Trade Trust") continues to innovate and optimize the insurance trust business, providing customers with one-stop wealth management services, making "guarding" more warm.

　　Insurance Trust is a trust established with the relevant rights and corresponding interests of life insurance contract as trust property. It aims to transfer the insurance premium to the trust account according to the contract when the insurance payment conditions occur, and the trust company will manage, use and dispose of the trust property according to the contract.

　　Compared with the traditional legal inheritance, will, gift and personal insurance, this model has many advantages. First, the threshold of establishment is lowered through the leverage of insurance and installment delivery, so that the trust can cover more customers with wealth management and inheritance needs; Second, through the professional management of insurance money, we can realize the risk isolation and protection of funds, preserve and increase their value, and realize long-term wealth inheritance; Third, based on the wider range of beneficiaries of the trust, it can provide more flexible customized property planning arrangements.

　　As a modern financial company dedicated to creating innovation-oriented, service-oriented entities and people-oriented, Foreign Trade Trust provides customers with convenient and efficient arrangements for setting up trust products by providing exclusive customized services, including whole-program services such as architecture design, trust management and asset allocation. As early as 2014, foreign trade trust started the research and practice of insurance trust business. In 2015, foreign trade trust landed the first insurance trust, and continued to innovate and optimize its business model with the changing needs of customers in the past decade.

　　As an innovative wealth management tool, insurance trust is gradually showing great market potential. Foreign Trade Trust said that it will always firmly practice the political and people-oriented nature of financial work, earnestly fulfill the social responsibilities of financial companies of central enterprises through various innovative trust businesses such as charity, special needs and property trust, and help a better life with the power of trust.

　　　Cctv news　 In the report of the 19th National Congress, the implementation of the "Healthy China" strategy has brought great benefits to the medical and health industry. In recent years, the health industry has developed rapidly and has been called "the global ‘ after the IT industry; Wealth The 5th Wave ’ " . The improvement of national policies, public concern and the promotion of the market have provided fertile ground for the development of large health industries.

　　In October 2016, the Central Committee of the Communist Party of China and the State Council issued "Healthy China ‘ 2030’ Planning Outline ",clearly raising" Healthy China "as a national development strategy; In the report of the 19th National Congress, the call of "implementing the strategy of healthy China and developing the healthy industry" was clearly reiterated. At the two sessions this year, the National Health Planning Commission changed its name to National Health Commission, and the development of health industry began to shift from "focusing on treating diseases" to "focusing on people’s health". "Preventing diseases" was regarded as the "new blue ocean", and the big health industry became a new "window".

　　The change of demand has led to the change of the traditional health industry model. The big health industry with "prevention, treatment and maintenance" as its main industry has ushered in the "blue ocean era". Some experts predict that the big health industry will reach 10.5 trillion in 2020, with unlimited development prospects. The big health industry has attracted many cross-border giants to compete, including Baidu, Ali, Suning, Tencent, China Resources, Evergrande, Vanke and so on.

　　Under the background of such a booming healthy China and benefiting the world, Chinese medicine practitioners are naturally indispensable. The Outline of Healthy China 2030 Plan puts forward that the unique advantages of Chinese medicine will be brought into full play, and the quintessence of Chinese medicine will be given a strong impetus in the new era. How will Chinese medicine enterprises pursue the wave of this era? The strategic cooperation between Beijing Youmei Bio and Beijing Tongrentang Xing ‘an League is a beneficial attempt to integrate and develop the big health industry.

　　Recently, Beijing Youmei Biotechnology Co., Ltd. (hereinafter referred to as "Youmei Bio") has reached a strategic cooperation with Beijing Tongrentang Xing ‘an League Chinese Herbal Medicine Co., Ltd. Youmei Bio is a compound and innovative biotechnology company, which has developed a variety of big health products that combine the essence of Chinese herbal medicine and modern quantum technology. Founded in 1669, Beijing Tongrentang is a time-honored brand in the Chinese medicine industry.

　　As practitioners of the concept of great health, the two sides will devote themselves to building a great health ecological industry with a new business model and help implement the development strategy of "Healthy China".

He Xianfeng, a professor of traditional Chinese medicine at Xing ‘an League in Beijing Tongrentang, took a group photo with Feng Bin, chairman and president of Wu Rongfang.

　　　During the cooperation, the founder of Youmei Bio announced the strategic plan of "building the industrial chain of Big Health Group in the future, screening mature production bases to the whole country, reforming enterprise management, upgrading customer service, building business school system and health service center". Wu Rongfang, chairman of Youmei Bio, said: "I hope that the resource platform of the enterprise will enable each enterprise to gain more and develop better in cooperation, truly exert its energy and driving role, and contribute to the big health industry!"

　　Without national health, there will be no overall well-off society! The big health industry is becoming an important driving force for economic growth. It can be predicted that with the continuous acceleration of consumption upgrading and people’s increasing attention to the quality of life and physical health, this industry will usher in an unprecedented golden development period.

　　At the two conferences held in a week, the Supreme Leader General Secretary emphasized the same key word — — People’s democracy in the whole process.

　　On September 14th, at the celebration of the 70th anniversary of the founding of the National People’s Congress, General Secretary of the Supreme Leader emphasized: "We should adhere to, improve and operate the people’s congress system around the development of people’s democracy in the whole process, so as to provide a solid institutional guarantee for realizing the goal of the party and the people in the new era and new journey."

　　On September 20th, at the celebration of the 75th anniversary of the founding of China People’s Political Consultative Conference, the Supreme Leader General Secretary pointed out: "Looking back at history and looking forward to the future, we should be more confident in road, theory, system and culture, give full play to the remarkable political advantages of the CPPCC in the whole process of developing people’s democracy, and constantly consolidate and develop a lively, stable and United political situation."

　　Why should "whole process people’s democracy" be placed in such an important position?

　　General Secretary Supreme Leader’s thinking on the whole process of people’s democracy has always been based on the broad vision of the great cause of national rejuvenation.

　　Looking back 10 years ago, General Secretary of the Supreme Leader looked back at the Party’s unremitting exploration and struggle to realize the people being the masters of the country and made an important conclusion — —

　　"People’s democracy is the life of socialism. Without democracy, there will be no socialism, no socialist modernization, and no great rejuvenation of the Chinese nation. "

　　Extend the lens of time again.

　　General Secretary of the Supreme Leader has repeatedly mentioned the "cave-cave pairing" between Comrade Mao Zedong and Mr. Huang Yanpei in Yan ‘an. That was in the summer of 1945. Facing the question of how to jump out of the historical cycle rate, Comrade Mao Zedong confidently replied: "We have found a new way, and we can jump out of this cycle rate. This new road is democracy. "

　　Wind and rain, the road is boundless.

　　On November 2, 2019, General Secretary of the Supreme Leader clearly pointed out — —

　　"We are following a road of political development in Socialism with Chinese characteristics, and people’s democracy is a democracy in the whole process".

　　In October 2021, at the work conference of the Central People’s Congress, the General Secretary of the Supreme Leader made a systematic and incisive exposition on the major concepts and practical requirements of people’s democracy in the whole process.

　　Once put forward, "people’s democracy in the whole process" immediately attracted great attention at home and abroad. It is precisely because of this great concept that based on the understanding of the development law of democratic politics, the "master key" and "master switch" for realizing democracy have been identified.

　　The whole process of people’s democracy, for whom?

　　People being masters of their own affairs is the essence and core of democracy in China. Since its birth, the Communist Party of China (CPC) has made unremitting exploration and struggle to realize that the people are the masters of the country.

　　Jiangshan belongs to the people, and Jiangshan is crowned with the people. "The name of our country, the name of our state organs at all levels, are titled ‘ People ’ This is our basic orientation for the socialist regime in China. "

　　Capitalized "people" paves the way for the whole process of people’s democracy. Whether it is holding a conference to deliver an important speech or going deep into the grassroots investigation and research; Whether meeting with Chinese and foreign journalists or having a cordial discussion with people from all walks of life, the Supreme Leader General Secretary repeatedly stressed: respect the people’s dominant position and ensure that the people are masters of their own affairs.

　　Who does people’s democracy depend on in the whole process?

　　Socialist China has developed from a backward agricultural country to a world power with the second largest economic aggregate and strong comprehensive national strength. It has eliminated absolute poverty, created a miracle in the history of human poverty reduction, and built the world’s largest education system, social security system and medical and health system … … Without the people’s status and spirit of ownership, without the United struggle of hundreds of millions of people, how can such achievements be achieved?

　　At present, the changes of the world, the times and the history are constantly expanding in breadth and depth, and the arduous and arduous task of China’s reform, development and stability is unprecedented. In the critical period of comprehensively promoting the construction of a strong country and the great cause of national rejuvenation with Chinese modernization, only by fully stimulating the enthusiasm, initiative and creativity of all the people can we have a solid support and strong confidence to cope with risk challenges, difficulties and even stormy waves.

　　What is the weight and strength of the people? General Secretary of the Supreme Leader said: "China has a population of more than 1.4 billion. Who can match the strength and wisdom of hundreds of millions of people?"

　　The whole process of people’s democracy is combined with great practice and develops with the times.

　　"The whole process of people’s democracy not only has complete institutional procedures, but also has complete participation in practice, which is extensive, true and useful."

　　In August this year, faced with the speakers attending the 40th anniversary of the National People’s Congress’s accession to the Inter-Parliamentary Union and the Sixth Seminar for Parliamentarians from Developing Countries, General Secretary of the Supreme Leader pointed out that one of the most important experiences of China’s remarkable achievements in governance was that it took the road of political development in Socialism with Chinese characteristics under the leadership of the Communist Party of China and adhered to and developed people’s democracy throughout the process.

　　Extensive, authentic and effective democratic achievements are strongly supported by "full chain, all-round and full coverage".

　　In a big country with a vast territory, a large population and complicated national conditions, it is not easy to truly express and realize the wishes of more than 1.4 billion people, and it must be guaranteed by the system.

　　"Both history and reality show that a stable system leads to a stable country, and a strong system leads to a strong country." The 20th National Congress of the Communist Party of China made comprehensive arrangements for developing people’s democracy in the whole process and ensuring that people are masters of their own affairs, and the Third Plenary Session of the 20th Central Committee of the Communist Party of China made specific arrangements for improving the system of people’s democracy in the whole process … … We will develop people’s democracy in the whole process, so that various systems can better reflect people’s will, protect people’s rights and interests, stimulate people’s creativity, and use institutional systems to ensure that people are masters of their own affairs.

　　In recent years, some countries have seen phenomena such as democratic alienation and disorderly governance, which has given birth to deep thinking about the relationship between democracy and state governance in the international community. How to ensure the benign interaction between democratic development, political stability and social progress? How to overcome the phenomenon that the people in some countries have the right in form but not in fact, and make promises all over the sky during the election and no one asks after the election? China’s exploration and practice vividly explained that "people’s democracy is a glorious banner that the Communist Party of China (CPC) has always held high" and explored a new path for the development of human democracy.

　　Unswervingly follow the road of political development in Socialism with Chinese characteristics, adhere to and improve China’s fundamental political system, basic political system and important political system, constantly improve the system of people being masters of their own affairs, enrich democratic forms at all levels, expand people’s orderly political participation, fully embody people’s will, safeguard people’s rights and interests, and stimulate people’s creative vitality.

　　Complete institutional procedures and participation in practice make the whole process of people’s democracy change from value concept to institutional form, governance mechanism and people’s lifestyle rooted in China.

　　"The whole process of people’s democracy in China is based on China’s national conditions, history and culture and reflects the wishes of the people. We are equally proud." The words of the Supreme Leader General Secretary show pride in the whole process of people’s democracy and confidence in Socialism with Chinese characteristics’s political development path, which has become a portrayal of the whole party and the people of all ethnic groups in China who are full of confidence in the great cause.

　　Self-confidence is the only way to improve yourself. We should learn from the beneficial achievements of human political civilization, but never copy the western political system model.

　　Practice has fully proved that the whole process of people’s democracy is feasible, vital and efficient because it grew from the social soil of China, and it must be deeply rooted in the social soil of China if it is to continue to thrive in the future.

　　Looking far and wide, and putting democracy in the perspective of "the common value of all mankind", the significance of China’s active development of people’s democracy in the whole process is even broader.

　　When in some countries "excess democracy", "excessive democracy" and "deficit democracy" coexist, and when the myth of "what’s wrong with democracy" and "does democracy still work" arises, "the Communist Party of China (CPC) led the people of China to make great achievements in developing people’s democracy, which enriched the theory and practice of world democracy and contributed to China’s wisdom and China’s plan."

　　"Democracy is not an ornament, not for decoration, but for solving problems that people need to solve."

　　"Democracy is the right of people of all countries, not the patent of a few countries."

　　The unique concept of democracy contained in Chinese modernization was formed in the process of promoting socialist modernization, and it was put forward on the basis of summing up the process of human modernization, which provided a useful reference for human exploration of a better political system.

　　"We are willing to continue to explore with all countries and people in the world who pursue peace, development, fairness, justice, democracy and freedom the way to realize extensive, true and effective democracy and make new contributions to the progress of human political civilization." The words of the Supreme Leader’s General Secretary are extremely important, based on the common pursuit of democracy by all mankind, and full of deep concern for the future and destiny of mankind.

　　Planning: Zhang Yi, Du Shangze

　　Written by Zhao Cheng

　　Poster: Li Yan

　　Vision: Bi Xiaoyang and Yu Dongsheng

　　Photography: Xinhua News Agency reporter Xie Huanchi and Ju Peng.

　　Editor: Jiang Xuehong

　　Proofreading: Julie

　　Editor in charge: Jiang Xuehong

April 23rd this year is the 30th "World Reading Day". In recent years, Shandong, Hubei, Guizhou and other places have promoted the construction of shared reading spaces such as urban study rooms and staff reading rooms. By entering communities, parks and construction sites, they have created a reading atmosphere with rich books, realizing that "books are everywhere, books are always floating, and books are enjoyed by everyone", which has deepened the cultural heritage of the city.

Entering the community: the "cultural charging station" at home.

Mr. Liu, a citizen of Zhucheng, Weifang City, Shandong Province, came to the Haiyan study room next to his own community. There is not much room here, but there are 15,000 books in the library, and you can borrow them for free. For Mr. Liu, Haiyan’s study is a "spiritual home" built in front of his home. He said, "It’s very convenient to walk around the corner after dinner. This study has a large collection of books and a wide range of knowledge, which really provides reading convenience for the people near us. "

In a space of more than 350 square meters, various books such as history and literature are dazzling. Many community residents quietly enjoy reading time. As the cultural service platform of Zhucheng’s new era civilization practice, Haiyan study room is connected with Zhucheng library, where books can be borrowed and returned. Mr. Zhang, a citizen, said: "My family lives nearby. The study environment is good and there are many books. You can come at any time if you want to read."

With the help of urban study, Zhucheng has created a diversified public cultural space and integrated culture into life. The relevant person in charge said: "We strive to create a spiritual pure land, let everyone share their reading experience, and make reading more books and reading good books a way of life, which is a kind of promotion and help for personal spiritual growth and the current construction of a scholarly society."

In spring, Fangfei is good, and reading is just the time. Recently, a 24-hour city study was officially launched in a community in Economic Development Zone, Jingzhou City, Hubei Province. Walking into it, warm yellow lights and wooden bookshelves set each other off. There are more than 3,000 books covering social sciences, literature and art, children and other fields, which can meet the reading needs of readers of all ages.

"You can enter by swiping your ID card, and you can go at any time if you want to read at night." "In the past, I had to drive to the city library to borrow books. Now there is a city study at my doorstep, and it is really convenient for children to borrow books themselves after school." Residents who come to read books are full of praise for the city study at the door of this house. It is understood that there is a self-service book borrowing and returning machine and an intelligent security system in the city study. Residents can swipe their ID cards to enter the study, borrow and return books, and the community will regularly arrange special personnel for cleaning and maintenance. The relevant person in charge said that the study room has created a good reading atmosphere for community residents and is becoming a "cultural charging station" at home.

Entering the park: looking down at the book and looking up at the scenery.

Located in the scenic Guanshan Lake Park, Luming Bookstore in Guiyang City, Guizhou Province, takes the concept of "nature as a companion, book fragrance moistens the heart" and devotes itself to creating a multi-featured reading space integrating knowledge dissemination, ecological education, leisure experience and communication. At present, there are more than 40 reading seats and a service window, and there are more than 5,000 books in the collection, mainly in natural sciences, covering biological sciences, earth sciences, environmental sciences and other sub-categories. Focusing on ecological protection and sustainable development, it echoes the green concept of parks, promotes the integration of nature and humanities, and at the same time, it is supplemented by books on classic literature, life tourism and parenting education, taking into account the diverse reading needs and creating a reading atmosphere for the whole people. The bookstore is also equipped with a self-service borrowing and returning machine to make the reading experience more efficient and intimate.

According to reports, in addition to the Luming Bookstore, Guanshanhu Park will welcome two new bookstores this year. One is the "Tanruo Bookstore Cafe" whose name is taken from "hugging together like pomegranate seeds" and symbolizes the great unity of the Chinese nation. It will be located around the National Grand Gala Square in Guanshanhu Park; The other is the "Zhixing Bookstore" with the urban spirit of Guiyang as the main creative concept, which will be located near Qiannan Gate of Guanshanhu Park.

In Danxia Cultural and Sports Park in Qingshan Lake District, Nanchang City, Jiangxi Province, a white building resembling a conch stands near the water, with floor-to-ceiling windows reflecting the lake light, and spiral wooden bookshelves winding upward, attracting passers-by to stop frequently. As a new cultural landmark, Conch Bookstore has received more than 1,000 readers per day with its unique design concept and rich cultural activities since its opening in 2022. "It’s not as serious as a traditional library, but it’s like walking into a landscape painting." Mr. Wang said.

Entering the Conch Bookstore, the 270-degree floor-to-ceiling window around the lake frames the water color into a natural painting. The whole row of atmospheric wooden bookshelves perfectly echoes the curve of the lake shore, and the whole row of four-lane waterfall lending and display system is very eye-catching; The room with circular arch inside, seagull-shaped lighting, wavy ceiling and minimalist wooden decoration style can feel the small and exquisite design concept everywhere. This 1,500-square-meter city study has nearly 30,000 books, which is a cultural service space integrating reading and sharing, public lectures, art curation, activities and exchanges.

Entering the construction site: supplementing "spiritual food" for builders

At the site of the first phase project of Anhe New Port, the central port area of Anqing Port, Anqing City, Anhui Province, a site library of more than 10 square meters was built. The space was not large, but it soon became an important place for builders to supplement "spiritual food". "It is not unusual to have a bookstore on the construction site. The key is how to give full play to its role and make it truly serve the vast number of builders." The person in charge of the project department said.

There are a large number of books in the library to help project personnel prepare for the first-class construction engineer, registered safety engineer and other certificate examinations. In order to improve learning efficiency, everyone comes here to study by themselves. "The professional books in our library are very rich. I am reading the Code for Welding of Steel Structures recently to enrich my professional knowledge." Looking at the dazzling array of bookshelves, a worker said happily. At present, the site library contains more than 300 books of all kinds, which not only meets the dual needs of front-line employees in culture and skills, but also creates a good atmosphere of "striving to be a learning employee and building a learning project".

The staff bookstore of the headquarters of China Railway 16th Bureau was established in 2018, with more than 1,000 books, including Chinese studies, current politics, literature and popular science. The biggest feature of the library is its mobility. It is a mobile staff library converted from containers, which is convenient for display and use in surrounding construction sites such as Beijing, Tianjin and Hebei. There are computers, computer desks, reading desks, tea makers and coffee makers in the library, making the "staff library" a good platform for learning.

From china construction news, April 23, 2025, Su Yuan.

Information picture

In July, 2023, polymyxin B sulfate for injection, an exclusive drug produced by a subsidiary of Shanghai Pharmaceutical Group, suddenly announced that it had dropped from 2,303 yuan/branch to 270 yuan/branch, with a drop of nearly 90%, which attracted the attention of the industry.

The reporter learned from official website, State Administration of Market Supervision, that the decision of administrative punishment on the case of abuse of market dominance by four companies, such as Shanghai Shangyao No.1 Biochemical Pharmaceutical Co., Ltd., was recently released. According to the decision, in July 2023, the Shanghai Municipal Market Supervision Administration initiated an investigation into the abuse of market dominance by four companies, including SAIC Biochemical. In December 2023, Shanghai Municipal Market Supervision Administration made an administrative punishment decision on this case according to law. The punishment decision shows that during the period from December 2017 to June 2023, four pharmaceutical companies abused the dominant position in the market of polymyxin B sulfate for injection in China, and implemented the behavior of selling preparations at unfairly high prices, which excluded and restricted market competition and harmed the interests of patients and social public interests.

Well-known anti-monopoly law experts pointed out in an interview that the above four companies were fined 1.219 billion yuan for violating the Anti-monopoly Law of the People’s Republic of China, which is the case with the largest amount of anti-monopoly punishment in the pharmaceutical field at present.

Monopolize the API market

Polymyxin B sulfate for injection plays an important role in the treatment of carbapenem-resistant gram-negative bacteria infection, which is highly dependent on hospitals and patients and difficult to be replaced by other drugs. Before 2017, no domestic company produced its raw materials and medicines and needed to import them from abroad.

According to the circular of the State Administration of Market Supervision, three private pharmaceutical companies, Wuhan Huihai Pharmaceutical Co., Ltd., Wuhan Kede Pharmaceutical Co., Ltd. and Hubei Minkang Pharmaceutical Co., Ltd., and the state-owned pharmaceutical company Shanghai Pharmaceutical Group Shangyao No.1 Biochemical Pharmaceutical Co., Ltd., abused the dominant position in the market of polymyxin B sulfate for injection in China and implemented the act of selling preparations at unfair high prices.

Wuhan Huihai, Wuhan Kede and Minkang Pharmaceutical (collectively referred to as Wuhan Huihai) have the same actual controlling shareholders, confused personnel and office locations, unified decision-making, division of labor and cooperation, jointly implemented the acts involved, and shared monopoly profits.

In order to introduce and control its raw materials, in 2010, Wuhan Huihai signed an agreement with Danish Yaseli Company to become the agent of Danish Yaseli China market. Since 2016, Wuhan Huihai has given the sales manager of Danish Yaseli China a benefit fee, asking him not to sell the API to other enterprises, thus controlling the supply of the whole API in China market.

On the other hand, Wuhan Huihai is busy looking for manufacturers. Because only the drug is qualified for production in China, it has not been put into production. Wuhan Huihaisui reached a cooperation intention with Shanghai Pharmaceutical Biochemical Co., Ltd. to supply raw materials to Shanghai Pharmaceutical Biochemical Co., Ltd., which was responsible for drug declaration and production, and granted exclusive distribution rights to its preparations, from which Shanghai Pharmaceutical Biochemical collected processing fees. Shanghai Pharmaceutical Biochemical applied for production qualification, and obtained the production approval from the Food and Drug Administration in 2017, becoming the only production enterprise in China.

According to the Shanghai Municipal Market Supervision Bureau, operators must first have APIs for R&D and production when entering the market, while Wuhan Huihai controls the supply of APIs in the China market, so it is difficult for other operators to obtain APIs. It is reported that this is the second time that Wuhan Huihai was punished by pharmaceutical antitrust in 2023. In May 2023, the State Administration of Market Supervision fined him 4,126,800 yuan. Wuhan Huihai Pharmaceutical Co., Ltd. was established in 2003 with a registered capital of 3 million yuan, and its legal representative is Li Meilin.

Conspire to earn excess profits

Shanghai Pharmaceutical Biochemical Co., Ltd. belongs to Shanghai Pharmaceutical Group, with total assets of 800 million yuan and registered capital of 225 million yuan.

When Wuhan Huihai signed a cooperation agreement with Shanghai Pharmaceutical Biochemical Co., Ltd., it was agreed that when bidding for preparations, the two sides would negotiate and communicate on matters such as bidding price and distributors, and jointly agree on bidding matters. According to the rules of drug sales, Shanghai Pharmaceuticals Biochemistry came forward to connect with the drug recruitment departments of all provinces in the country, made online quotations, and invoiced and sold them to circulation enterprises according to the instructions of Wuhan Huihai to obtain the sales income of preparations.

As the only operator who sells the drug, Shangyao Biochemical has the ability to influence and determine the key trading conditions such as sales price and sales quantity. The price of the drug was 2303 yuan/piece in Fujian province for the first time, and then it reached 2918 yuan/piece in Shanghai. Since then, the provinces have hung up their nets one after another, and the prices are mostly 2303 yuan/branch to 2918 yuan/branch. According to the instructions of Wuhan Huihai, Shanghai Pharmaceutical Biochemical Co., Ltd. supplies the goods to the circulation enterprises after deducting the distribution fee according to the hanging price.

In 2016, the state began to implement the "two-vote system" policy, that is, drugs are invoiced once from the production enterprise to the circulation enterprise and once from the circulation enterprise to the medical institution, with the aim of reducing the circulation of drugs and lowering the price of drugs. Limited by the "two-vote system", Wuhan Huihai can’t directly obtain the monopoly profit of preparation sales by buying low and selling high. To this end, Wuhan Huihai, with the cooperation of Shanghai Pharmaceutical Biochemical Co., Ltd., obtained monopoly profits from the raw materials link by inflating the sales price of raw materials.

Due to the large amount of payment for raw materials, Wuhan Huihai arranged for 38 pharmaceutical companies in Hubei and Jiangxi to increase prices step by step, and gradually pushed up the import price of raw materials purchased from Danish Yaseli Company from 73 yuan/g to 94 yuan/g to 18,000 yuan/g to 35,000 yuan/g, and sold them to Shanghai Pharmaceutical Biochemical Company to produce preparations, from which profits were made. This creates the illusion that the high drug price is due to the high drug price of raw materials.

Drive up drug prices for nearly six consecutive years.

According to the Shanghai Municipal Market Supervision Bureau, in 2022 alone, the illegal income of Wuhan Huihai was 610 million yuan, and that of Shanghai Pharmaceutical was 330 million yuan. The biochemical behavior of Wuhan Huihai and Shanghai Pharmaceutical Co., Ltd. constitutes the abuse of market dominance to sell goods at unfairly high prices.

It is reported that the cost of drug production is mainly composed of two parts: the cost of raw materials and the cost of biochemical workshop. According to the biochemical financial data of Shanghai Pharmaceutical Co., Ltd., the total production cost of this drug is about 8.6 yuan -14.6 yuan/piece, and the processing fee charged by Shanghai Pharmaceutical Co., Ltd. is from 140.4 yuan/piece -230 yuan/piece. Finally, the net price of the drug is as high as 2303 yuan/piece -2918 yuan/piece.

In addition, the domestic sales price of polymyxin B sulfate for injection is significantly higher than that of other countries and regions in the same period, which is about 35 to 44 times that of overseas products.

"The serious handling of this case corrected the illegal behavior in time, and the drug price dropped by nearly 90%. This safeguards the interests of consumers and the public interest. " In an interview, Wang Xianlin, a member of the Expert Advisory Group of the State Council Anti-monopoly Committee and vice president of china law society Economic Law Research Association, pointed out that the parties in this case abused their dominant market position to sell drugs at unfairly high prices. On the one hand, they distorted the market price formation mechanism of this drug and made its price seriously deviate from the normal level, which excluded and restricted market competition. On the other hand, it also makes patients have to pay higher prices, increases the cost of medication for patients, and seriously damages the interests of patients; It also increased the expenditure of the national medical insurance fund, which seriously damaged the public interest.

The reporter learned that after the above-mentioned case was investigated in July 2023, six senior executives of Shanghai Pharmaceutical Group were investigated. In September 2023, Pan Deqing, former vice president of Shanghai Pharmaceutical, Li Ping, general manager of Shanghai Shangke Pharmaceutical, Chen Binhua, former general manager of Shanghai Pharmaceutical Biochemical, and Huang Yuhui, former deputy general manager of Shanghai Pharmaceutical Biochemical, were investigated. In November, Zhou Jun, chairman of Shanghai Pharmaceutical, and Gu Haoliang, former vice president of Shanghai Pharmaceutical, were investigated.

　　1. (000027) Shenzhen Energy: Supplement to the proposal of the second extraordinary shareholders’ meeting in 2008.

　　On March 25, 2008, Shenzhen Energy received a letter from Shenzhen Energy Group Co., Ltd. (the controlling shareholder of the company, holding 63.74% of the company’s shares), requesting the second extraordinary shareholders’ meeting in 2008 to consider the Proposal on Bidding for the Land of Shenzhen Energy Headquarters Building.

　　According to relevant regulations, the company submitted the new proposal to the second extraordinary general meeting of shareholders held on April 7, 2008 for consideration.

　　2. (000034)SST Shentai: The second prompt for holding the shareholders’ meeting related to the share-trading reform on March 28th.

　　1. Convenor: the board of directors of the company.

　　2. Time for convening the extraordinary shareholders’ meeting and relevant shareholders’ meeting:

　　On-site meeting time: Friday, March 28th, 2008, 9:00-11:30.

　　Online voting time: March 26th, 2008-March 28th, 2008.

　　Among them, the specific time for online voting through the trading system of Shenzhen Stock Exchange is:

　　From March 26th, 2008 to March 28th, 2008, every trading day is from 9: 30 to 11: 30 and from 13: 00 to 15: 00; It ended at 15:00 on March 28th, 2008.

　　The specific time for voting through the Internet is from 9: 30 on March 26th, 2008 to 15:00 on March 28th, 2008.

　　3. date of record: 24 March 2008

　　4. Site meeting place: meeting room of Shenzhen Huabao (Group) Feed Co., Ltd., northwest of the intersection of National Highway 107 and Xixiang Avenue, Baoan District, Shenzhen.

　　5. Meeting mode: combining on-site voting with online voting.

　　6. Matters to be considered at the meeting: Reform Plan of the Company’s Non-tradable Shares

　　3. (000035)ST Kejian: The board of directors passed the proposal of the company to carry out major asset restructuring and purchase assets through non-public offering of shares.

　　The 10th (temporary) meeting of the 4th Board of Directors of ST Kejian was held on March 24th, and the following proposals were considered and passed:

　　I. Proposal on the Company Meeting the Conditions for Non-public Offering of Shares;

　　2. Proposal on the Company’s Major Asset Restructuring and Non-public Offering of Shares to Purchase Assets;

　　3. To request the shareholders’ meeting to approve the proposal that zhu zhiping and his concerted actions are exempted from increasing the company’s shares by way of offer;

　　IV. "About the signing of the company with the Debt Committee, Kejian Group, Zhixiong Electronics, Tongli Company and Mr. Hao Jianxue"<框架协议>Proposal ";

　　V. About the signing of the Company with zhu zhiping, Ji Lisong, Cong Naikang and Tongli Company

　　VI. Proposal on Requesting the General Meeting of Shareholders to authorize the Board of Directors to handle matters related to major asset restructuring and non-public offering;

　　VII. Proposal on Submitting to the General Meeting of Shareholders for deliberation and approval on amending the Articles of Association;

　　VIII. Proposal on Temporarily Not Convening the Company’s General Meeting of Shareholders.

　　The company will hold another meeting of the board of directors to make supplementary resolutions on the above-mentioned related matters, and announce the time for convening the shareholders’ meeting separately.

　　4. (000035)ST Kejian: The first extraordinary general meeting of shareholders in 2008 was held on April 22nd.

　　1. Convening time: April 22nd, 2008 (Tuesday) at 1: 30pm.

　　2. Venue: Meeting room on the second floor of Kejian Building, Gongye Sixth Road, Shekou, Shenzhen.

　　3. Convenor: the board of directors of the company.

　　4. Convening method: on-site voting.

　　5. date of record: April 15, 2008

　　6. Matters to be considered at the meeting:

　　(1) Proposal on electing Mr. Du Changxi as the director of the fourth board of directors of the company;

　　(2) Proposal on reappointing Wuhan Zhonghuan Certified Public Accountants Co., Ltd. as the company’s financial auditing unit in 2007.

　　5. (000157) Zoomlion: The board of directors agreed to acquire the equity of Shaanxi Xinhuanggong Machinery Co., Ltd. and increase its capital.

　　The third interim meeting of the third board of directors of Zoomlion in 2008 was held on March 25th, and the following resolutions were passed:

　　1. Proposal on Acquisition of the Equity of Shaanxi Xinhuanggong Machinery Co., Ltd.;

　　2. Proposal on Capital Increase of Shaanxi Xinhuanggong Machinery Co., Ltd.;

　　III. Proposal on Authorizing the Chairman of the Board of Directors to Handle Stock Purchase, Capital Increase and Other Related Matters.

　　6. (000400) Xu Ji Electric: Main financial indicators and distribution plan of 2007 annual report.

　　I. Main financial indicators of the 2007 annual report

　　1. Earnings per share (RMB) 0.3066.

　　2. Net assets per share (RMB) 5.6331

　　3. ROE (%) 5.44

　　2. Send 1 yuan for every 10 shares (including tax).

　　7. (000421) North Nanjing: Major Events

　　In view of the background of national energy conservation and emission reduction policy, Changzhou Saide Thermal Power Co., Ltd., a holding subsidiary of Nanjing Zhongbei Holding Company, is facing the closure of power business. As Changzhou Saide is a Sino-foreign cooperative enterprise, the company is actively communicating and coordinating with relevant government departments on the above-mentioned power business shutdown and asset disposal, so as to avoid or reduce the possible impact on the company’s operating performance and safeguard shareholders’ rights and interests.

　　8. (000429) Guangdong Expressway A: Major events, the company’s shares will be suspended from March 26th.

　　Guangdong Expressway A is planning major asset restructuring matters, and will provide policy consultation and scheme demonstration to relevant departments within five working days after the publication of this announcement, so there are still uncertainties in related matters.

　　In order to protect the interests of investors and avoid significant impact on the company’s stock price, the company’s stock was suspended from March 26, 2008 upon the company’s application.

　　9. (000488) Chenming Paper Co., Ltd.: It intends to continue to provide guarantee for the relevant holding subsidiaries to apply for the comprehensive credit line of RMB in 2008.

　　On March 24, 2008, the sixth meeting of the fifth board of directors of Chenming Paper reviewed and passed the "Proposal on Providing Guarantee for Holding Subsidiaries to Apply for Bank Credit Line". The 2007 annual credit guarantee provided by the company for its holding subsidiaries has expired one after another. In order to ensure the normal production and operation of each holding subsidiary, the company intends to continue to provide guarantee for the relevant holding subsidiaries to apply for the comprehensive credit line of RMB in 2008, with a total guarantee amount of 2.25 billion yuan and a term of one year.

　　10. (000502) Lvjing Real Estate: Main financial indicators and distribution plan of the 2007 annual report.

　　I. Main financial indicators of the 2007 annual report

　　1. Earnings per share (RMB) 0.0239

　　2. Net assets per share (RMB) 1.08.

　　3. ROE (%) 2.21

　　Second, no distribution and no increase

　　11. (000530) Great Cold B: Abnormal fluctuations in stock trading.

　　The trading price of Dalang B stock was abnormal in the two consecutive trading days from March 24 to 25, 2008, which was a stock price change.

　　At present, the company does not have any matters or information that should be disclosed but not disclosed.

　　12. (000543) Wanneng Electric Power: Main financial indicators and distribution plan in 2007 annual report.

　　I. Main financial indicators of the 2007 annual report

　　1. Earnings per share (RMB) 0.08

　　2. Net assets per share (RMB) 6.82

　　3. ROE (%) 1.21

　　2. Pay 0.85 yuan (including tax) for every 10 shares.

　　13. (000543) Wanneng Electric Power: The 2007 Annual General Meeting of Shareholders was held on April 29th.

　　1. Meeting time: 9:00 am on Tuesday, April 29th, 2008.

　　2. Meeting place: Conference Room 5, 4th floor, Wanneng Building, No.99 Maanshan Road, Hefei, Anhui.

　　3. Convenor of the meeting: the board of directors of the company.

　　4. Method of meeting: On-site voting.

　　5. date of record: April 21, 2008

　　6. Matters considered at the meeting: Report on the Company’s Profit Distribution Plan for 2007, etc.

　　14. (000559) Wanxiang Qian Chao: The annual general meeting of shareholders passed the profit distribution plan for 2007.

　　The 2007 Annual General Meeting of Shareholders of Wanxiang Qian Chao was held on March 25th, 2008, and the following resolutions were passed:

　　1. Work Report of the Board of Directors in 2007.

　　2. Work Report of the Board of Supervisors in 2007.

　　3, 2007 annual financial statements.

　　4. Profit distribution plan for 2007.

　　5. Report on the implementation of related party transactions in 2007 and proposal on the forecast of daily related party transactions in 2008.

　　15. (000565) Chongqing Three Gorges A: The board of directors agreed to provide a one-year working capital loan guarantee of 20 million yuan for the holding subsidiary of Three Gorges Yingli Chemical.

　　The Eighth Board of Directors of the Fifth Session of Chongqing Three Gorges A was held on March 24th, and the proposal to provide a one-year working capital loan guarantee of 20 million yuan for Chongqing Three Gorges Yingli Chemical Co., Ltd., a holding subsidiary of the company, was reviewed and passed.

　　Chongqing Three Gorges Yingli Chemical Co., Ltd. is a holding subsidiary of the company. Its newly-built 50,000-ton glycine/year project is progressing normally and has entered the trial production stage. In order to ensure the completion and production of the project, the company decided to apply for a one-year working capital loan of RMB 20 million from China Merchants Bank Chongqing Branch Jiulongpo Sub-branch, and the company provided guarantee for it.

　　16. (000568) LU ZHOU LAO JIAO CO.,LTD: The performance in the first quarter of 2008 is expected to increase by 250%-300% year-on-year.

　　LU ZHOU LAO JIAO CO.,LTD predicted that the accumulated net profit from January to March 2008 would increase by 250% to 300% compared with the same period of last year, and the net profit attributable to shareholders of listed companies would also increase by more than 250% to 300% compared with the same period of last year.

　　The reasons are:

　　1. The first quarter is the traditional peak season for liquor sales, and the company arranged ahead of schedule. The leading products such as Guojiao 1573 and Luzhou Laojiao Tequ have a good sales situation and the sales volume has increased rapidly;

　　2. As of March 31, 2008, the company held 353,164,800 shares of Huaxi Securities (accounting for 34.86% of the total shares of Huaxi Securities), an increase of 333,164,800 shares compared with the same period of last year, so the investment income increased accordingly.

　　17. (000594) Tianjin Hongfeng: Shenzhen Guoheng sold 8,907,300 shares of the company again.

　　From March 20, 2008 to March 25, 2008, Shenzhen Guoheng Industrial Development Co., Ltd., a shareholder of Tianjin Hongfeng, has sold a total of 8,907,300 shares of the company through listing on Shenzhen Stock Exchange, accounting for 1.59% of the total shares of the company.

　　As of March 25th, 2008, Shenzhen Guoheng still holds 80,686,613 shares (accounting for 14.38% of the total shares of the company).

　　18. (000617) Petroleum firewood: main financial indicators and distribution plan of the 2007 annual report.

　　I. Main financial indicators of the 2007 annual report

　　1. Earnings per share (RMB) 0.41

　　2. Net assets per share (RMB) 2.81

　　3. ROE (%) 14.52

　　2. Send 0.2 yuan for every 10 shares (including tax).

　　19. (000625) Changan Automobile: The 2007 Annual General Meeting of Shareholders was held on April 25th.

　　(1) Convening time: 9:00 am on April 25th, 2008.

　　(II) Venue: Multimedia Meeting Room of Chang ‘an Science and Technology Building, No.260 Jianxin East Road, Jiangbei District, Chongqing.

　　(3) Convenor: the board of directors of the company.

　　(4) Convening method: on-site voting method.

　　(5) date of record: April 18, 2008.

　　(VI) Matters to be considered at the meeting: 2007 annual report and summary, profit distribution in 2007 and plan for converting capital reserve into share capital, etc.

　　20. (000625) Changan Automobile: Main financial indicators and distribution plan in 2007 annual report.

　　I. Main financial indicators of the 2007 annual report

　　1. Earnings per share (RMB) 0.34

　　2. Net assets per share (RMB) 3.89

　　3. ROE (%) 8.81

　　2. Transfer 2 shares for every 10 shares.

　　21. (000631)S*ST Lanbao: The annual report for 2007 will be disclosed before March 29th.

　　S*ST Lanbao’s 2007 financial audit was carried out ahead of schedule, and the audit report will be completed around March 27th, 2008. Therefore, the company’s original time to disclose the 2007 annual report on April 25th, 2008 will be advanced to March 29th, 2008.

　　22. (000652) TEDA Co., Ltd.: Main financial indicators and distribution plan of the 2007 annual report.

　　I. Main financial indicators of the 2007 annual report

　　1. Earnings per share (RMB) 0.35

　　2. Net assets per share (RMB) 1.93.

　　3. ROE (%) 18.24

　　Two, send 3 shares for every 10 shares, and send 0.34 yuan (including tax) to increase 1 share.

　　23. (000652) TEDA: The 2007 annual general meeting of shareholders was held on April 28th.

　　1. On-site meeting time: 2: 00pm on Monday, April 28th, 2008, with a duration of half a day;

　　Online voting time: the online voting time through the trading system is from 9: 30 am to 11: 30 am and from 13: 00 pm to 15: 00 pm on April 28, 2008; The specific time for voting through the Internet voting system of Shenzhen Stock Exchange is from 15:00 pm on April 27th, 2008 to 15:00 pm on April 28th, 2008.

　　2. Venue: Tianjin Tianma International Club Co., Ltd. (address: next to Tianjin Yangliuqing Golf Club, west of Jingfu Highway, Shuangkou Town, Beichen District, Tianjin);

　　3. Convenor: the board of directors of the company;

　　4. Convening method: combining on-site method with online voting;

　　5. date of record: April 21, 2008;

　　6. Matters considered at the meeting: the company’s profit distribution plan for 2007, and the proposal of the company to subscribe for new shares with idle funds in 2008.

　　24. (000655) Jinling Mining: The non-public offering of shares to purchase assets was approved by the state-owned assets management department.

　　Jinling Mining recently received a reply from the State-owned Assets Supervision and Administration Commission of Shandong Provincial People’s Government, agreeing that the company will issue no less than 30 million shares and no more than 50 million shares in a non-public manner to purchase auxiliary assets such as Zhaokou Branch Mine, power plant and some land workshops of Shandong Jinling Iron Mine.

　　25. (000671) Sunshine Development: The 2007 Annual General Meeting of Shareholders was held on April 17th.

　　1. Convenor of the meeting: the board of directors of the company;

　　2. Meeting time: 9:30 am on Thursday, April 17th, 2008;

　　3. Meeting place: Meeting room of Sunshine Holiday Hotel, No.26 Gao Qiao Road, Fuzhou;

　　4. Method of convening the meeting: voting on the spot;

　　5. date of record: April 10, 2008;

　　6. Matters considered at the meeting: The Full Text of the Company’s 2007 Annual Report and its Summary, and the Proposal on the Company’s 2007 Profit Distribution and Converting the Provident Fund into Share Capital, etc.

　　26. (000671) Sunshine Development: Main financial indicators and distribution plan of the 2007 annual report.

　　I. Main financial indicators of the 2007 annual report

　　1. Earnings per share (RMB) 0.18

　　2. Net assets per share (RMB) 2.71

　　3. ROE (%) 6.74

　　2. Pay 0.35 yuan (including tax) for every 10 shares.

　　27. (000677) Shandong Hailong: The performance in the first quarter of 2008 increased by 50%-150% in advance.

　　Shandong Hailong expects that the net profit in the first quarter of 2008 will increase substantially compared with the same period of last year, and it is expected to increase by 50%-150% in the same direction.

　　The reasons are as follows: in the first quarter of 2008, the company was affected by technological upgrading, and the sales of new products increased; In addition, the company’s income from intangible assets and the reduction of income tax rate are affected.

　　28. (000693)S*ST Juyou: The board of directors agreed to hire Zhongyuan International Assets Appraisal Co., Ltd. as an asset appraisal agency.

　　The 24th Board of Directors of the 6th Session of S*ST Juyou held a meeting by fax on March 25th, 2008, and passed the Proposal on Hiring Zhongyuan International Assets Appraisal Co., Ltd. as an Assets Appraisal Agency.

　　29. (000709) Tangshan Iron and Steel Co., Ltd.: The performance in the first quarter of 2008 is expected to increase by 50%-100%.

　　In the first quarter of 2008, the net profit attributable to the owner of the parent company of Tangshan Iron and Steel Co., Ltd. is expected to increase by 50%-100% year-on-year.

　　The reasons are:

　　1. The company increased the cooperation scope of strategic resources and reduced the procurement cost of main raw materials.

　　2. The second phase project of Tangshan Medium Plate Co., Ltd., a holding subsidiary of the company, was put into operation in the first quarter of 2008, which increased the production capacity and benefit.

　　3. The company strives to optimize the variety structure and increase the proportion of high value-added products.

　　4. The company vigorously carried out energy conservation and emission reduction, developed circular economy, deepened benchmarking and tapped potential, and optimized various major economic and technical indicators.

　　30. (000739) Prokangyu: Main financial indicators and distribution plan of the 2007 annual report.

　　I. Main financial indicators of the 2007 annual report

　　1. Earnings per share (RMB) 0.1247

　　2. Net assets per share (RMB) 2.78

　　3. ROE (%) 4.27

　　Second, no distribution and no increase

　　31. (000819) Yueyang Xingchang: Progress of New Drug Evaluation of Gastropathy Vaccine

　　The Drug Evaluation Center of the State Food and Drug Administration held a drug evaluation consultation meeting in Beijing from March 20 to 22, 2008, and conducted an expert evaluation consultation on the "oral recombinant Helicobacter pylori vaccine" (gastropathy vaccine) declared by Chongqing Kangwei Biotechnology Co., Ltd., a subsidiary of Yueyang Xingchang.

　　The review consultation meeting ended on schedule on March 22nd. According to the convention of the consultation meeting, its opinions have not been officially informed to Chongqing Kangwei and announced. According to the website of Drug Evaluation Center of State Food and Drug Administration (website: http://www.cde.org.cn), at present, the consultation and discussion of gastropathy vaccine has ended and entered the stage of "post-consultation review", and "five biological products review rooms are conducting comprehensive evaluation according to the consultation opinions".

　　32. (000819) Yueyang Xingchang: 40,791,244 restricted shares were listed and circulated on March 28th.

　　The number of tradable shares listed under this restricted sale condition is 40,791,244 shares.

　　The circulating date of the tradable shares with limited sale conditions is March 28, 2008.

　　33. (000835) Sichuan Shengda: The board of directors approved the proposal of lending 50 million yuan to hengfeng bank Chengdu Branch, and appointed Chang Feng as the executive deputy general manager of the company.

　　The 24th meeting of the 5th Board of Directors of Sichuan Shengda was held on March 25th, 2008, and the following resolutions were passed:

　　I. Proposal on the Company’s loan of RMB 50 million to hengfeng bank Chengdu Branch.

　　2. To appoint Mr. Chang Feng as the executive deputy general manager of the company.

　　34. (000851) Gaohong Shares: The 2007 Annual General Meeting of Shareholders was held on April 28th.

　　1. Convening time: 9: 00 am on April 28th, 2008.

　　2. venue: meeting room on the third floor of the main building of Datang Telecom Group, No.40 Xueyuan Road, Haidian District, Beijing.

　　3. Convening method: on-site voting method.

　　4. Convenor: Board of Directors

　　5. date of record: April 21, 2008

　　6. Main agenda of the meeting: Proposal of the Company’s 2007 Annual Report and Summary, Proposal of the Company’s 2007 Annual Profit Distribution, etc.

　　35. (000851) Gaohong Co., Ltd.: Main financial indicators and distribution plan of the 2007 annual report.

　　I. Main financial indicators of the 2007 annual report

　　1. Earnings per share (RMB) 0.04

　　2. Net assets per share (RMB) 1.93.

　　3. ROE (%) 2.12

　　Second, no distribution and no increase

　　36. (000897) Jinbin Development: Main financial indicators and distribution plan of the 2007 annual report.

　　I. Main financial indicators of the 2007 annual report

　　1. Earnings per share (RMB) 0.0643.

　　2. Net assets per share (RMB) 1.87.

　　3. ROE (%) 3.43

　　Two, every 10 shares of 0.2 yuan (including tax) increased by 4 shares.

　　37. (000897) Jinbin Development: The performance in the first quarter of 2008 is expected to increase by 50%-100%.

　　Jinbin Development predicts that the net profit in the first quarter of 2008 will increase by 50%-100% year-on-year.

　　In March, 2008, the company received a penalty of RMB 35.286 million from Tianjin TEDA Investment Holding Co., Ltd., which had an impact on the company’s operating performance in the first quarter.

　　38. (000897) Jinbin Development: The 2007 Annual General Meeting of Shareholders was held on April 18th.

　　(1) Meeting time: 10:00 am on Friday, April 18th, 2008.

　　(II) Meeting place: meeting room on the 11th floor of the company.

　　(3) Convenor: the board of directors of the company.

　　(4) Meeting method: voting on the spot.

　　(5) date of record: April 11, 2008.

　　(VI) Matters considered at the meeting: Proposal on the Company’s Profit Distribution Plan for 2007, etc.

　　39. (000901) Aerospace Science and Technology: The disclosure of the 2007 annual report was postponed to April 23rd.

　　Because the annual financial audit of Aerospace Science and Technology could not be completed within the expected time, the disclosure time of the company’s 2007 annual report was postponed to April 23, 2008 with the approval of Shenzhen Stock Exchange.

　　40. (000903) Power in the Cloud: Supplement to the 2007 Annual Report

　　Yunnei Power disclosed its 2007 annual report and abstract on March 8, 2008. In order to enable investors to know more about the company in detail, we now make a supplementary announcement on the relevant contents of the company’s 2007 annual report and abstract.

　　41. (000916) North China Expressway: The 2007 Annual General Meeting of Shareholders was held on April 18th.

　　1. Meeting time: 10:00 am on Friday, April 18th, 2008.

　　2. Meeting place: A301 meeting room of the company.

　　3. Convenor: the board of directors of the company.

　　4. Method of meeting: On-site voting by secret ballot.

　　5. date of record: April 10th, 2008.

　　6. Matters considered at the meeting: profit distribution plan for 2007, etc.

　　42. (000916) North China Expressway: Main financial indicators and distribution plan in 2007 annual report.

　　I. Main financial indicators of the 2007 annual report

　　1. Earnings per share (RMB) 0.286.

　　2. Net assets per share (RMB) 3.46

　　3. ROE (%) 8.27

　　2. Send 1.6 yuan for every 10 shares (including tax).

　　43. (000917) Dianguang Media: 2007 annual performance report, with earnings per share of 0.33 yuan.

　　Main financial data and indicators in 2007:

　　Earnings per share (RMB) 0.33

　　Return on net assets (%) 6.52

　　Net assets per share (RMB) 5.14

　　44. (000917) Dianguang Media: The extraordinary shareholders’ meeting passed the proposal to provide financial support for the holding subsidiaries.

　　The first extraordinary shareholders’ meeting of Dianguang Media in 2008 was held on March 25th, and the Proposal on Providing Financial Support for Hunan Xinfengyuan Investment Co., Ltd., a holding subsidiary, was passed.

　　45. (000931) Zhongguan Village: Major Litigation Progress

　　Beijing Plastics Trading Co., Ltd. and Beijing Longtianlu Real Estate Development Co., Ltd. sued Beijing Zhongguancun Development and Construction Co., Ltd., a holding subsidiary of Zhongguan Village, for the dispute over the infringement of equity transfer. The plaintiffs Plasticizing Company and Longtianlu Company applied to the court to withdraw the lawsuit. The court allowed to withdraw the lawsuit after examination, and the case acceptance fee of 61,866,500 yuan was borne by Plastics Company and Longtianlu Company. This case will not affect the company’s performance in 2007 and 2008.

　　46. (000931) Zhongguan Village: Progress of Major Events

　　After deliberation and approval at the second interim meeting of the third board of directors of Zhongguan Village in 2008, the company decided to suspend the sale of the equity of Beijing Zhongguancun Sihuan Pharmaceutical Development Co., Ltd. and applied to the China Securities Regulatory Commission to withdraw the Report on the Sale of Major Assets and Related Transactions. As the largest shareholder of the company, Pengtai Investment agreed to the company’s decision to suspend the sale of Sihuan Co., Ltd., and promised to buy Sihuan Co., Ltd. again at no less than 400 million yuan when the conditions are ripe. If other potential investors participate in the bidding, the highest bidder will win the bid.

　　On March 25th, 2008, the company received the relevant notice from the China Securities Regulatory Commission, and the China Securities Regulatory Commission decided to terminate the examination of the company’s application.

　　47. (000936) Huaxi Village: The board of directors agreed to acquire 75% equity of Jiangyin Chengyi Storage Co., Ltd. owned by Chenghua International.

　　The 24th Extraordinary Meeting of the Third Board of Directors of Huaxi Village was held on March 25th, and the Proposal on the Company’s Acquisition of 75% Equity of Jiangyin Chengyi Storage Co., Ltd. owned by Chenghua International Co., Ltd. was reviewed and approved.

　　48. (000973) Fosu shares: lease matters.

　　On March 21st, 2008, Fosu Co., Ltd. signed the Workshop and Equipment Lease Contract with Wuxi Zhenghan Iron and Steel Trading Co., Ltd., and the company plans to lease the 9,189.69 square meters workshop and a batch of equipment (including power supply facilities) located at No.226 Fenglin Road, Chancheng District, Foshan City to Zhenghan Company for use.

　　The rent is 1.1 million yuan per year and 1.1 million yuan per year (that is, 91,666.67 yuan/month).

　　The lease term is five years from April 1, 2008 to March 31, 2013.

　　This transaction does not constitute a connected transaction.

　　49. (002001) Xinhecheng: On March 28th, an online briefing on the 2007 annual report was held.

　　Xinhecheng will hold the 2007 annual report briefing session on the online platform provided by Shenzhen Securities Information Co., Ltd. from 15: 00 to 17: 00 on Friday, March 28, 2008. This annual report briefing session will be held by remote network, and investors can visit Panorama: http://irm.p5w.net to participate in the annual report briefing session.

　　Present at the briefing session of this annual report were Mr. Hu Baifan, Chairman of the Company, and others.

　　50. (002030) Daan Gene: Main financial indicators and distribution plan of the 2007 annual report.

　　I. Main financial indicators of the 2007 annual report

　　1. Earnings per share (RMB) 0.28

　　2. Net assets per share (RMB) 2.43

　　3. ROE (%) 11.49

　　2. Send 2 shares for every 10 shares, and send 1.3 yuan (including tax) to increase 4 shares.

　　51. (002030) Daan Gene: The 2007 Annual General Meeting of Shareholders was held on April 16th.

　　(1) Meeting time: starting at 9:30 am on April 16th, 2008.

　　(II) Venue: Lecture Hall, 1st floor, No.19 Xiangshan Road, Guangzhou Economic and Technological Development Zone, Guangdong Province.

　　(III) Convening method: on-site convening.

　　(4) date of record: April 9, 2008

　　(V) Agenda of the meeting: Proposal on Profit Distribution and Capitalization of Capital Reserve Fund in 2007, Annual Report of 2007 and its summary, etc.

　　52. (002036) Yike Technology: The board of directors agreed to invest in the establishment of Ningbo Hanma Industrial Product Development Co., Ltd.

　　The fifth meeting of the third board of directors of Yike Technology was held on March 25th, and it was agreed that the company and the holding company-Hanma Industrial Investment Holding Co., Ltd. jointly invested to establish Ningbo Hanma Industrial Product Development Co., Ltd. The registered capital of Ningbo Hanma Company is RMB 18 million, of which RMB 9 million is contributed by the company, accounting for 50% of the registered capital; Hanma Holdings invested 9 million yuan, accounting for 50% of the registered capital.

　　53. (002048) Ningbo Huaxiang: The performance in the first quarter of 2008 is expected to increase by 60%-90%.

　　Ningbo Huaxiang’s estimated performance in the first quarter of 2008: the net profit attributable to the owners of the parent company increased by 60%-90% compared with the same period of last year.

　　The reasons are:

　　1. The domestic passenger car industry has maintained a rapid development. The company’s main customers, Shanghai Volkswagen, FAW-Volkswagen, Shanghai GM and FAW Toyota, rank in the top ten in sales volume, and the sales volume of the company’s supporting parts has also increased.

　　2. The products supplied by the company have developed in the direction of assembly and modular supply. The batch supply of assembly finished products has improved the matching value of bicycles, thus driving the rapid growth of the company’s sales revenue and profitability.

　　3. The company’s related foreign investment in 2007 generated benefits.

　　54. (002064) huafeng spandex: The transaction fluctuated abnormally.

　　As of March 25th, 2008, the deviation of daily closing price of huafeng spandex stock has reached 20% in three consecutive trading days, which is an abnormal fluctuation of stock trading.

　　The company’s net profit in the first quarter of 2008 is expected to drop by less than 50% compared with the same period of last year. Except for the above matters, the company’s business activities are normal, and there is no information that should be disclosed but not disclosed at present.

　　55. (002065) Donghua Hechuang: The Board of Directors adopted the working rules for the review of the annual report of the Audit Committee of the Board of Directors.

　　The third meeting of the third board of directors of Donghua Hechuang was held on March 25th, 2008, and the following resolutions were passed:

　　1. Measures for the Administration of the Company’s Shares Held by Directors, Supervisors and Senior Management and Their Changes;

　　2. Working Rules for Review of the Annual Report of the Audit Committee of the Board of Directors of the Company;

　　3. Work System for Annual Reports of Independent Directors of the Company.

　　56. (002078) Sun Paper: The board of directors passed the proposal of external guarantee of the company’s holding subsidiary.

　　The 13th Board of Directors of the third session of Sun Paper was held on March 25th, and the Proposal on External Guarantee of the Company’s Holding Subsidiary was reviewed and approved.

　　57. (002083) Vosges shares: The annual general meeting of shareholders adopted the company’s annual report for 2007 and its summary.

　　The 2007 annual general meeting of shareholders of Vosges was held on March 25th, and the following proposals were reviewed and passed:

　　1. Work Report of the Board of Directors for 2007;

　　2. Work Report of the Board of Supervisors in 2007;

　　3. Annual Report of the Company in 2007 and its Summary;

　　4. Report on the Company’s 2007 Annual Financial Statements;

　　5. Proposal on the Company’s Profit Distribution in 2007 and Converting Capital Reserve into Share Capital;

　　6. Proposal on Determining Allowances for Independent Directors;

　　7. Proposal on Remuneration of Directors, Supervisors and Senior Management;

　　8. Proposal on Planning to Apply to Agricultural Development Bank for Comprehensive Credit of not more than 1 billion yuan;

　　9. Proposal on Providing a Total Guarantee of RMB 1.2 billion for Shandong Vosges Photovoltaic Technology Co., Ltd., a wholly-owned subsidiary;

　　10. Proposal on Renewing the Appointment of PricewaterhouseCoopers Zhongtian Certified Public Accountants.

　　58. (002093) Guomai Technology: external guarantee of holding subsidiary.

　　Guomai Zhongxun Network Technology (Hong Kong) Co., Ltd., a wholly-owned subsidiary of Guomai Zhongxun Network Technology Co., Ltd., a holding subsidiary of Guomai Technology, applied to CITIC Ka Wah Bank for a loan with a total amount of no more than US$ 6 million for a period of no more than eight months.

　　On March 25th, 2008, Guomai Zhongxun provided guarantee for the loan that Guomai Zhongxun (Hong Kong) applied for with a total amount of no more than USD 6 million. As of the date of this announcement, Guomai Zhongxun provided guarantee for the loan of Guomai Zhongxun (Hong Kong) with a total amount of USD 14 million (USD: RMB =1:7.09), equivalent to RMB 99.26 million, accounting for the company (including holding subsidiaries).

　　59. (002096) Nanling civil explosion: main financial indicators and distribution plan of 2007 annual report.

　　I. Main financial indicators of the 2007 annual report

　　1. Earnings per share (RMB) 0.635.

　　2. Net assets per share (RMB) 4.74

　　3. ROE (%) 13.39

　　Two, every 10 shares to send 3 yuan (including tax) to increase by 5 shares.

　　60. (002096) Nanling Civil Explosion: The 2007 Annual General Meeting of Shareholders was held on April 21st.

　　(1) Time of the meeting: 9:00 am on April 21st, 2008.

　　(II) Form of meeting: on-site meeting.

　　(3) Place of the meeting: Nanhua Hotel, Yongzhou City, Hunan Province.

　　(4) date of record: April 16, 2008

　　(5) Convenor of the meeting: the board of directors of the company.

　　(VI) Matters to be considered: Plan for Profit Distribution and Capital Reserve Fund Transfer to Share Capital in 2007, Annual Report and Summary of Annual Report of the Company in 2007, etc.

　　61. (002123) Rongxin shares: 23,201,961 shares issued before the initial public offering were listed and circulated on March 28th.

　　The number of shares issued before the initial public offering of Rongxin was 24,953,528, and the actual number of shares available for listing and circulation was 23,201,961. The listing and circulation date was March 28, 2008.

　　62. (002132) Stellar Technology: Prompt for Holding the 2007 Annual General Meeting of Shareholders on March 30th.

　　1. Meeting time: 9:00 am on March 30th, 2008 (Sunday).

　　2. Meeting place: company meeting room.

　　3. Convenor of the meeting: the board of directors of the company.

　　4. Mode of meeting: on-site meeting.

　　5. date of record: March 26th, 2008.

　　6. Meeting topics: 2007 Annual Report and Summary of the Company, 2007 Profit Distribution Plan of the Company, etc.

　　63. (002133) Guangyu Group: 12 million yuan was awarded by the government.

　　According to the relevant documents issued by Shangcheng District People’s Government of Hangzhou on February 3, 2008, in order to encourage the successful listing of Guangyu Group, the government gave the company a listing reward and support of 12 million yuan. The company has recently received this fund.

　　64. (002144) Hongda Warp Knitting: Notice of Holding the 2007 Annual General Meeting of Shareholders on April 18th.

　　(1) Meeting time: 2 pm on Friday, April 18th, 2008.

　　(2) date of record: April 11, 2008

　　(III) Meeting place: conference room on the 10th floor of Hongda Building, No.218 Haizhou Road, Haining.

　　(IV) Method of convening the meeting: voting on the spot.

　　(5) Convenor of the meeting: the board of directors of the company.

　　(VI) Matters considered at the meeting: Company II? ? Full text and abstract of seven-year annual report, Company II? ? Seven-year profit distribution plan of the company, etc.

　　65. (002144) Hongda Warp Knitting: Main financial indicators and distribution plan of 2007 annual report.

　　I. Main financial indicators of the 2007 annual report

　　1. Earnings per share (RMB) 0.23

　　2. Net assets per share (RMB) 2.75.

　　3. ROE (%) 7.09

　　2. Send 1 yuan for every 10 shares (including tax).

　　66. (002151) Big Dipper: Main financial indicators and distribution plan of 2007 annual report.

　　I. Main financial indicators of the 2007 annual report

　　1. Earnings per share (RMB) 0.85.

　　2. Net assets per share (RMB) 4.74

　　3. ROE (%) 14.82

　　Two, every 10 shares of 2.5 yuan (including tax) increased by 7 shares.

　　67. (002151) Big Dipper: The 2007 Annual General Meeting of Shareholders was held on April 16th.

　　1. Meeting time: 9: 00 am on April 16th, 2008.

　　2. Meeting place: the second meeting room of the company.

　　3. Convenor of the meeting: the board of directors of the company

　　4. Method of meeting: On-site voting.

　　5. date of record: 11 April 2008

　　6. Matters to be considered at the meeting: 2007 Annual Report and its summary, 2007 Profit Distribution Plan, etc.

　　68. (002154) Good news bird: the performance in the first quarter of 2008 is expected to increase by 45%-75%.

　　The good news bird predicts that the net profit attributable to the owners of the parent company will increase by 45%-75% in the first quarter of 2008 compared with the same period of last year.

　　The reasons are as follows: with the promotion of brand awareness and reputation, the added value of the brand has increased, the sales revenue has increased, the gross profit margin has increased, and the corporate income tax rate has decreased from 33% to 25%.

　　69. (002165) Hongbaoli: The distribution plan for 2007 was implemented, and every 10 shares were sent to 3 yuan (including tax) and 5 shares were added.

　　Hongbaoli’s profit distribution and capitalization of capital reserve fund in 2007. This plan is to distribute cash bonus 3 yuan for every 10 shares (including tax, after tax deduction, individual shareholders and investment funds actually send 2.7 yuan cash for every 10 shares), and increase 5 shares for every 10 shares.

　　Date of record: April 2, 2008;

　　Ex-dividend date: April 3, 2008;

　　The dividend payment date is April 3, 2008.

　　70. (002167) Dongfang Zirconium Industry: The 2007 Annual General Meeting of Shareholders was held on May 15th.

　　1. Meeting time: 03:00 pm on Thursday, May 15th, 2008.

　　2. Meeting place: conference room on the fourth floor of the company office building.

　　3. Convenor: the board of directors of the company.

　　4. Convening method: on-site voting.

　　5. date of record: May 9, 2008

　　6. Matters considered at the meeting: Profit Distribution Plan of the Company in 2007, Annual Report and Summary of the Company in 2007, etc.

　　71. (002167) Dongfang Zirconium Industry: Main financial indicators and distribution plan in 2007 annual report.

　　I. Main financial indicators of the 2007 annual report

　　1. Earnings per share (RMB) 0.51

　　2. Net assets per share (RMB) 4.29

　　3. ROE (%) 9.74

　　2. Send 0.5 yuan for every 10 shares (including tax).

　　72. (002172) Aoyang Technology: The annual general meeting of shareholders adopted the company’s 2007 annual report and its summary.

　　Aoyang Technology’s 2007 Annual General Meeting of Shareholders was held on March 25th, and the following resolutions were passed:

　　1. Report on the Work of the Board of Directors in 2007;

　　2. Work Report of the Board of Supervisors of the Company in 2007;

　　3. Report on the Company’s 2007 Annual Financial Statements;

　　4. Annual Report of the Company in 2007 and its Summary;

　　5. Special Report on the Use of Funds Raised by the Company in 2007;

　　6. The Company’s 2007 Annual Profit Distribution and the Plan for Converting Capital Reserve Fund into Capital Stock;

　　7. Proposal of the Audit Committee’s Resolution on Renewing the Appointment of Accounting Firms;

　　8. Proposal on Allowances and Expenses of Independent Directors;

　　9. Proposal on Daily Related Party Transactions of the Company in 2008.

　　73. (002185) Huatian Technology: Main financial indicators and distribution plan of the 2007 annual report.

　　I. Main financial indicators of the 2007 annual report

　　1. Earnings per share (RMB) 0.6052

　　2. Net assets per share (RMB) 4.53

　　3. ROE (%) 10.25

　　2. Transfer 5 shares for every 10 shares.

　　74. (002185) Huatian Technology: The 2007 Annual General Meeting of Shareholders was held on April 18th.

　　1. Convenor of the meeting: the board of directors of the company.

　　2. Meeting time: 10:00 am on Friday, April 18th, 2008.

　　3. Meeting place: Meeting room on the 7th floor of Huatian Apartment, No.14 Shuangqiao Road, Qinzhou District, Tianshui City, Gansu Province.

　　4. Voting method at the meeting: on-site voting method.

　　5. date of record: April 11th, 2008.

　　6. Meeting Matters: 2007 Annual Report and Summary, 2007 Profit Distribution and Plan for Converting Capital Reserve into Capital Stock, etc.

　　75. (002189) Lida Optoelectronics: Main financial indicators and distribution plan of the 2007 annual report.

　　I. Main financial indicators of the 2007 annual report

　　1. Earnings per share (RMB) 0.21

　　2. Net assets per share (RMB) 2.26

　　3. ROE (%) 7.03

　　2. Send 0.5 yuan for every 10 shares (including tax).

　　76. (002189) Lida Optoelectronics: The 2007 Annual General Meeting of Shareholders was held on April 20th.

　　I. Meeting time: 9:00 am on April 20, 2008.

　　2. Meeting place: Meeting room on the third floor of Building 103 of the Company.

　　III. Convenor of the meeting: the board of directors of the company.

　　Iv. mode of meeting: voting by on-site voting.

　　V. date of record: April 14, 2008

　　Vi. Matters considered at the meeting: Profit Distribution Plan for 2007, Annual Report for 2007 and Summary of Annual Report for 2007, etc.

　　77. (002194) Wuhan Fangu: Main financial indicators and distribution plan of 2007 annual report.

　　I. Main financial indicators of the 2007 annual report

　　1. Earnings per share (RMB) 1.3925

　　2. Net assets per share (RMB) 7.9126

　　3. ROE (%) 13.54

　　2. Transfer 10 shares for every 10 shares.

　　78. (002194) Fangu, Wuhan: On April 2nd, an online briefing session on the 2007 annual report was held.

　　Wuhan Fangu is scheduled to hold an annual report briefing session on the online platform provided by Shenzhen Securities Information Co., Ltd. from 15: 00 to 17: 00 on Wednesday, April 2, 2008. The annual report briefing session will be held by remote network, and investors can log on to the investor interaction platform: http://irm.p5w.net to participate in this briefing session.

　　Present at the briefing session of this annual report were Mr. Meng Qingnan, Chairman of the Company, and others.

　　79. (002194) Wuhan Fangu: The 2007 Annual General Meeting of Shareholders was held on April 16th.

　　(I) Convenor of the meeting: the board of directors of the company.

　　(II) Convening time: 9: 30am on Wednesday, April 16th, 2008.

　　(3) date of record: April 10, 2008

　　(IV) Venue of the on-site meeting: No.1 conference room on the fourth floor of Denso Building of the company.

　　(V) Convening method: on-site voting method.

　　(VI) Matters considered at the meeting: 2007 Annual Report of the Company and its summary, 2007 Annual Profit Distribution Plan of the Company, etc.

　　80. (002204) Huarui Cast Steel: On March 31, 2007, an online presentation meeting on the annual performance was held.

　　Huarui Cast Steel will hold an online presentation on its 2007 annual performance on the online platform provided by Shenzhen Securities Information Co., Ltd. from 15: 00 to 17: 00 on Monday, March 31, 2008. This performance online briefing will be held in a remote way. Investors can visit Panorama http://irm.p5w.net to participate in the annual report briefing.

　　Present at the performance briefing were Mr. Song Jiajing, the chairman of the company, and others.

　　81. (002208) Hefei Urban Construction: The Board of Directors adopted the Articles of Association (amendment).

　　The 10th meeting of the 3rd Board of Directors of Hefei Urban Construction was held on March 24th, 2008, and the following resolutions were passed:

　　1. Rules of Procedure of the Board of Directors (Amendment);

　　2. Rules of Procedure for Shareholders’ General Meeting (Amendment);

　　3. Articles of Association (Amendment);

　　4. Work System for Independent Directors (Amendment);

　　5. Decision System for Related Party Transactions (Amendment);

　　6. Rules on Major Decision-making Procedures (Revised);

　　7. Management System of Raised Funds (Amendment);

　　8. Information Disclosure System (Amendment);

　　9. The Management System of Executive Stock Ownership and Its Change;

　　10. Investor Relations Management System;

　　11. Work System for Annual Reports of Independent Directors;

　　12. Work Rules for the Annual Report of the Audit Committee.

　　82. (002216) Sanquan Food: The board of directors passed the proposal of replacing the self-raised funds of the investment projects that have been invested with raised funds in advance with raised funds.

　　The 6th meeting of the 3rd Board of Directors of Sanquan Food was held on March 25th, 2008, and the following resolutions were passed:

　　I. Proposal on Replacing Self-raised Funds of Investment Projects with Raised Funds in advance.

　　II. Proposal on Resignation of Ms. Li Rong as Deputy General Manager.

　　83. (002219) Unique flavor: The 2007 annual general meeting of shareholders was held on April 18th.

　　1. Convening time: April 18th, 2008 (Friday) from 9: 00 am to 12: 00 am, with a duration of half a day.

　　2. date of record: April 11th, 2008.

　　3. Meeting place: Jiayuan International Hotel, No.181 Airport Road, Chengdu.

　　4. Convenor of the meeting: the board of directors of the company.

　　5. Meeting method: on-site voting.

　　6. Meeting topics: Proposal on Profit Distribution in 2007, etc.

　　84. (200152) Shandong Airlines B: The 2007 Annual General Meeting of Shareholders was held on April 22nd.

　　1. Meeting time: April 22, 2008 at 10:00 am, with a duration of half a day.

　　2. Meeting place: meeting room on the 31st floor of Shandong Aviation Building, No.5746, Second Ring East Road, Lixia District, Jinan.

　　3. Convenor: the board of directors of the company.

　　4. Convening method: on-site voting.

　　5. date of record: April 17, 2008

　　6. Matters considered at the meeting: 2007 Annual Report of the Company and its summary, 2007 Profit Distribution Plan of the Company, etc.

　　85. (200429) Guangdong Expressway A: Major events, the company’s shares were suspended from March 26th.

　　Guangdong Expressway A is planning major asset restructuring matters, and will provide policy consultation and scheme demonstration to relevant departments within five working days after the publication of this announcement, so there are still uncertainties in related matters.

　　In order to protect the interests of investors and avoid significant impact on the company’s stock price, the company’s stock was suspended from March 26, 2008 upon the company’s application.

　　86. (200488) Chenming Paper Co., Ltd.: It intends to continue to provide guarantee for the relevant holding subsidiaries to apply for the comprehensive credit line of RMB in 2008.

　　On March 24, 2008, the sixth meeting of the fifth board of directors of Chenming Paper reviewed and passed the "Proposal on Providing Guarantee for Holding Subsidiaries to Apply for Bank Credit Line". The 2007 annual credit guarantee provided by the company for its holding subsidiaries has expired one after another. In order to ensure the normal production and operation of each holding subsidiary, the company intends to continue to provide guarantee for the relevant holding subsidiaries to apply for the comprehensive credit line of RMB in 2008, with a total guarantee amount of 2.25 billion yuan and a term of one year.

　　87. (200530) Great Cold B: Abnormal fluctuations in stock trading.

　　The trading price of Dalang B stock was abnormal in the two consecutive trading days from March 24 to 25, 2008, which was a stock price change.

　　At present, the company does not have any matters or information that should be disclosed but not disclosed.

　　88. (200625) Changan Automobile: Main financial indicators and distribution plan of 2007 annual report.

　　I. Main financial indicators of the 2007 annual report

　　1. Earnings per share (RMB) 0.34

　　2. Net assets per share (RMB) 3.89

　　3. ROE (%) 8.81

　　2. Transfer 2 shares for every 10 shares.

　　89. (200625) Changan Automobile: The 2007 Annual General Meeting of Shareholders was held on April 25th.

　　(1) Convening time: 9:00 am on April 25th, 2008.

　　(II) Venue: Multimedia Meeting Room of Chang ‘an Science and Technology Building, No.260 Jianxin East Road, Jiangbei District, Chongqing.

　　(3) Convenor: the board of directors of the company.

　　(4) Convening method: on-site voting method.

　　(5) date of record: April 18, 2008.

　　(VI) Matters to be considered at the meeting: 2007 annual report and summary, profit distribution in 2007 and plan for converting capital reserve into share capital, etc.

Editor: Zhou Zhongxiao

　　Xinhua News Agency, Shanghai, March 28th Title: Legal interpretation of Wu Xiaohui’s case &mdash; &mdash; Interview with Professor Ruan Qilin of China University of Political Science and Law

　　Xinhua News Agency reporter Chen Fei, Huang Anqi

　　On March 28th, the Shanghai No.1 Intermediate People’s Court held a trial in the first instance to hear the case of Wu Xiaohui, the former chairman and general manager of Anbang Property Insurance Group Co., Ltd., who was suspected of fund-raising fraud and duty embezzlement. Weibo, the official of Shanghai No.1 Intermediate People’s Court, made a summary of the trial. The reporter interviewed Professor Ruan Qilin, an expert in criminal law and China University of Political Science and Law, and asked him to analyze and interpret the main legal issues involved in this case according to the facts and evidence of the case published by Guan Wei of Shanghai No.1 Intermediate People’s Court, as well as the relevant information published by relevant departments and media before.

　　Reporter: From the main criminal facts and evidence that the procuratorate accused the defendant of being suspected published by Weibo, the official of Shanghai No.1 Intermediate People’s Court, how do you think to evaluate the nature of these behaviors of the defendant in criminal law? What kind of serious social harm do these behaviors have?

　　Ruan Qilin: Defendant Wu Xiaohui used Anbang Property Insurance as a financing platform, and the amount of illegally selling investment-type insurance products exceeded the scale approved by the China Insurance Regulatory Commission, reaching more than 720 billion yuan, which was illegal. According to Article 1 of the Supreme People’s Court’s Interpretation on Several Issues Concerning the Specific Application of Laws in the Trial of Illegal Fund-raising Cases, (1) those who, without the approval of the relevant departments according to law, (2) publicize in the society, and (3) promise to repay the principal and interest or pay a return, and absorb funds from the public are illegal to absorb public deposits. Although Anbang Property Insurance controlled by Wu Xiaohui has been approved by the relevant departments to issue investment-type insurance products according to law, it is far beyond the scale of sales approved by the China Insurance Regulatory Commission (over-raised), and the over-raised part should be considered as "not approved by the relevant departments according to law", which is illegal. Its over-raised part is staggering, reaching more than 720 billion yuan, which contains great financial risks and has extremely serious social harm.

　　Defendant Wu Xiaohui, in the above-mentioned illegal fund-raising process, first, used deception to secretly increase the capital of Anbang Group and Anbang Property Insurance by over-raised premium funds of more than 77 billion yuan. According to the relevant regulations, shareholders must increase their capital to insurance companies with their own funds, and Wu Xiaohui secretly converted the premium funds raised in excess into shareholders’ funds as capital increase for Anbang Property Insurance and Anbang Group, which violated the law and invented solvency to the CIRC and the public. At the same time, Wu Xiaohui manipulated Anbang Group and Anbang Property Insurance to modify profits, adjust data, disclose false information, and continue to make false propaganda to the public. Deceive the public to buy its investment insurance products, resulting in a sharp expansion of the scale of over-raising. Second, illegal possession of huge illegal fund-raising funds (over-raised premiums). After Anbang Property & Casualty sold investment insurance with a predetermined income in its own name, according to Wu Xiaohui’s request, it concealed the over-raised premium to Anbang Group or transferred it to the industrial company actually controlled by Wu Xiaohui, leaving the supervision of the China Insurance Regulatory Commission and other regulatory authorities, thus realizing the purpose of Wu Xiaohui’s illegal possession of huge premium funds by himself or through the industrial company actually controlled by himself, and actually causing a fund gap of 65.2 billion yuan. Wu Xiaohui can only repay the old premium gap with new premium income, and so on, with the Ponzi scheme. According to Article 192 of the Criminal Law, "those who illegally raise funds by deception for the purpose of illegal possession &hellip; &hellip;” It constitutes a crime of fund-raising fraud.Wu Xiaohui used deception to illegally raise funds and illegally took some of the funds for himself, which was suspected of constituting a crime of fund-raising fraud.

　　At the same time, the defendant Wu Xiaohui took advantage of his position to instruct others to transfer the original Anbang property insurance premium to the industrial company he actually controlled for his own use by means of transfer without accounting, which met the constitutive requirements of the crime of occupational embezzlement, and the amount was 10 billion yuan, which was extremely huge.

　　Reporter: We noticed that the defendant’s illegal fund-raising behavior in this case was carried out by insurance institutions. In judicial practice, how to determine the illegality of the actual controller using legal financial institutions to raise funds illegally? How to identify its criminal purpose? How to distinguish between unit crime and individual crime of natural person?

　　Ruan Qilin: These questions you asked are very professional. First of all, about the illegality of this behavior. Although Anbang Property Insurance is a legal financial institution, its issuance of investment-type insurance products must be approved by the CIRC according to relevant regulations. It is illegal to sell investment insurance products without the approval of the CIRC or beyond the sales scale approved by the CIRC. Because super-scale sales and illegal fund-raising have the same financial risks and are equally harmful to investors. Moreover, because it is a legal financial institution, it is easier to gain the trust of the public, and it can quickly expand the scale of illegal fund-raising to form greater financial risks, which is more harmful to society. The scale of illegally raised funds in this case has rapidly expanded to more than 720 billion yuan, which is closely related to Wu Xiaohui’s use of the signboard of Anbang Property Insurance legal financial institutions. After the incident, the relevant government departments immediately took over Anbang Group, which reflected the seriousness of the financial risks it created and forced the government departments to take over. In recent years, illegal fund-raising cases, such as the largest "Easy Rent Treasure" case, involved only tens of billions of yuan, which is a drop in the bucket compared with the scale of illegal fund-raising in this case. The amount that this case was illegally occupied and could not be returned reached more than 65 billion yuan, far exceeding the fund-raising fraud cases such as "Easy Rent Treasure".

　　Secondly, about the defendant’s criminal purpose. According to Article 2 of the Supreme People’s Court’s Interpretation on Several Issues Concerning the Specific Application of Laws in the Trial of Illegal Fund-raising Cases, if illegal fund-raising by deception has one of the following circumstances, it can be considered as "for the purpose of illegal possession": (2) wantonly squandering fund-raising funds, resulting in the non-return of fund-raising; &hellip; &hellip; (5) Evading, transferring funds, concealing property and evading the return of funds; &hellip; &hellip; (8) Other circumstances in which the purpose of illegal possession can be identified. In this case, the defendant used fictitious equity investment, false shareholder dividends and other means to transfer the investment-type insurance product funds raised by Anbang Property Insurance to the industrial company actually controlled by him for possession and use, and has caused more than 65 billion yuan of premium funds to be returned. Enough to identify the purpose of illegal possession.

　　Third, whether it is a unit crime or an individual crime. This case should be considered as an individual crime such as the defendant, and should not be considered as a unit crime. First, the unit crime should reflect the unit will, while the management of Anbang Group, Anbang Property Insurance and other Anbang companies all reflect Wu Xiaohui’s personal will, which does not conform to the company’s operating rules and cannot make Wu Xiaohui’s personal will rise to the unit will. Second, the essential feature of unit crime is "for the benefit of the unit". A large number of facts in this case show that Wu Xiaohui made a personal decision and sought personal interests. According to Article 3 of the Supreme People’s Court’s Interpretation on Relevant Issues Concerning the Specific Application of Law in the Trial of Unit Crimes: "Whoever embezzles the name of a unit to commit a crime, and the illegal income is divided among the individuals who commit the crime, shall be convicted and punished in accordance with the provisions on crimes committed by natural persons". In this case, Wu Xiaohui illegally took tens of billions of premium funds for himself, which should be considered as a natural person crime. At the same time, in this case, Zhongyuan Anbang Property Insurance and Anbang Group had to bear the responsibility of paying more than 720 billion yuan of wealth management products illegally raised by Wu Xiaohui and others because of their illegal fund-raising and illegal possession of premium funds. It has suffered huge economic losses and financial risks, and it is also a victim.

　　Reporter: Generally, fund-raising fraud cases will cause great losses to fund-raising participants, but there is no actual loss of the insured in this case. Excuse me, Professor Ruan, does this situation affect the criminal evaluation?

　　Ruan Qilin: Actually, Anbang Property Insurance has already taken great risks. According to today’s trial, the total assets of Wu Xiaohui’s personal and industrial companies at the time of the incident were far below the funding gap. Wu Xiaohui has hollowed out Anbang Property Insurance by using false capital injection, false investment, and various pretexts to transfer premiums. Once the capital chain breaks, millions of investors will suffer huge losses. Fortunately, the government supervision department found the huge redemption risk in time, took over Anbang Group urgently, and went all out to prevent the risk from expanding. That is to say, the actual loss of investors has not yet occurred in this case, which is entirely due to the fact that the government regulatory authorities prevented Wu Xiaohui and others from committing crimes of illegal fund-raising and taking over Anbang Group. This should not reduce Wu Xiaohui and others’ guilt of encroaching on the original Anbang property insurance and Anbang Group property, using fraudulent methods to illegally raise funds and illegally occupying fund-raising funds.

　　Reporter: Wu Xiaohui’s two criminal facts in the prosecution are that he took the funds of financial institutions as his own, but some of them were identified as fund-raising fraud and some as duty crimes. Why are these two parts of criminal facts evaluated differently in law? Why can’t it be regarded as the crime of illegal use of funds?

　　Ruan Qilin: In the case of basically the same criminal modus operandi, the public prosecutor found that Wu Xiaohui constituted the crime of fund-raising fraud and the crime of occupational embezzlement respectively. The criteria for such identification were based on the nature of illegally occupied funds.

　　Generally speaking, after an investor buys the products of an insurance company, the funds are actually owned and controlled by the insurance company, and the actual controller’s transfer of possession by taking advantage of his position should be regarded as a duty crime or a crime of illegal use of funds. All the illegally occupied funds come from Anbang’s legal premium income.

　　In order to obtain a large amount of funds, the actual controller used financial institutions as a tool to illegally absorb funds from the public. For example, in this case, Wu Xiaohui sold investment-type insurance products beyond the scale approved by the China Insurance Regulatory Commission, which was illegal in fund-raising, and the defendant illegally transferred and occupied the huge amount of funds in illegal fund-raising. The illegally occupied funds came from the premium funds of investment products that Anbang had overpaid (illegally raised funds). In illegal fund-raising, using deception to illegally raise funds and transfer the illegal fund-raising funds for possession is a related act under the deliberate control, that is, illegal fund-raising and illegal possession of fund-raising funds, which cannot be divided and should be evaluated as a whole. Therefore, it is reasonable to identify this part as fund-raising fraud.

　　The crime of illegal use of funds is the illegal use of funds managed by the relevant management institutions in violation of state regulations. This crime cannot cover or include illegal sources of funds and illegal possession of funds. Wu Xiaohui, the defendant in this case, used Anbang Property Insurance to sell insurance products beyond the approved scale, which was illegal fund-raising, and this illegal fund-raising behavior could not be included in the crime of illegal use of funds. That is to say, the crime of illegal use of funds can only evaluate the illegal use of funds, but it cannot or is not enough to evaluate the illegal source of funds, that is, it cannot include the evaluation of illegal fund-raising behavior. For Wu Xiaohui’s illegal fund-raising behavior, only the crime of illegally absorbing public deposits or the crime of fund-raising fraud can accurately evaluate the illegality of his obtaining funds. In addition, the crime of illegal use of funds can not cover the illegal possession of funds, and the crime of fund-raising fraud can include not only the illegal acquisition of funds, but also the illegal possession of illegally acquired funds, as well as the domination, use and punishment on the basis of illegal possession. Therefore, only the crime of fund-raising fraud can completely evaluate Wu Xiaohui’s illegal fund-raising and illegal possession of illegally raised funds. If the crime of illegal use of funds is found, the evaluation of its illegal fund-raising and illegal possession of funds is omitted, and all its behaviors are not completely evaluated.

Zhiyi Automobile/Li Jingwen

Recently, the internal design of Huawei’s "Ask the World" was exposed, which caused extensive discussion in the industry. Huawei’s smart car brand "ask the world" has attracted countless eyes since its advent, and every time a new product goes on the market, it will cause heated discussion.

The internal planning of this exposure is even more surprising. The new luxury smart model, the M8, will be launched in the world. It is expected to be launched in 2025, and its pricing range and delivery time have been roughly determined, with a total price of 300,000-400,000. . Let’s take a look at it.

In terms of appearance, there are similarities between the border M8 and the border M9 from the rendering. The circular closed front face is equipped with a lighted "border" sign above the engine compartment cover. Compared with the border M9, the through headlight group appears smoother, while the starlight style on both sides makes the car look more exquisite. The long and narrow passages on both sides are somewhat similar to the border 9, and the lower part is covered with black decoration. The laser radar on the roof is also a highlight of Huawei’s intelligent driving system.

The side body is slender, and the hidden BC column is used. Compared with the M9, the lower part of the window of the new model is narrower and looks more concise. The concealed door handle is decorated with chrome-plated ornaments, which echoes the decorations at the fender, making the whole car more integrated. The new car wheel hub adopts the double-color wheel hub of M9, and there are more slender decorative strips on the side, with rough wheel eyebrows, which is both stable and powerful.

The tail is a penetrating taillight, and the design is in stark contrast to the front of the car. The high-position brake light is embedded in the middle of the roof spoiler, which is highly recognizable after lighting. Like M9, the design of AITO logo, transverse decorative strips and reflective strips makes the whole car more layered.

As for the interior, please refer to the M9. The central control adopts triple screen design, eye-catching LCD instrument screen, central control screen and co-pilot’s entertainment screen, all of which show the atmosphere of luxury and technology. The circular three-spoke steering wheel is equipped with physical buttons, electronic arms and HUD head-up display, and the air outlets at both ends are in a "back" structure, which looks more atmospheric as a whole. The auxiliary center console is equipped with operation mode knob and dual mobile phone wireless charging panel.

In addition, the length of the M8 car body is over 5,100mm, and it is designed with three rows of seats. The trunk space is spacious, which can meet the needs of family travel or official business. This kind of physical performance also makes the M8 in the market get a higher degree of attention.

In terms of intelligent driving, it is equipped with Huawei’s newly developed "Gankun ADS3.0" advanced intelligent driving system, which, combined with air suspension technology, allows users to have a higher intelligent driving experience. As for security issues, Huawei will certainly not be worse, because everyone knows Huawei’s accomplishments in intelligent technology.

At present, the specific power information is not clear. It is reported that the "Whale" 800V high-voltage battery pack will be used, the wire harness will be reduced by 80% and the thickness will be reduced by 16.4%. It only takes 5 minutes to supplement the cruising range of 150km, which means that the new car will have more advantages in charging.

Although the new car was launched a little late, its competitiveness in the market can not be ignored. According to the official, the starting price of this model is 359,800 yuan, and the highest price is 410,000 yuan, which is quite competitive among the models of the same class.

Huawei asked the industry whether it would consider launching more cost-effective models in the future, so as to better meet the needs of consumers. This is also something that is worth looking forward to. If we can launch some smart models with affordable prices, I think they will definitely be favored by the majority of users.

The original article of Zhiyou Automobile, please contact us if you need to reprint it.

* The picture is from the Internet. If it is infringing, please contact the author to delete it. *

originate

Not long ago, the National Health and Wellness Commission and other six departments jointly formulated the "Second Batch of Rare Diseases Catalogue", which newly included 86 rare diseases. Together with the first batch of 121 rare diseases included in 2018, at present, there are 207 rare diseases included in the catalogue in China.

In recent years, the word "rare disease" has appeared more and more frequently in everyone’s field of vision. For example, in the news, the father developed "self-made medicine" for his son’s complex disease, and then in the past two years, the price negotiation of medical insurance was hot, and most of them were related to rare disease drugs.

The "drug god father", who was known on the Internet in 2021, took his son to be injected with gene therapy drugs in June 2022, and was also the first patient with Menkes disease who underwent gene therapy in China | See the watermark for the source.

In the past two years, the medical insurance price negotiations have always been hot headlines, and drugs related to rare diseases are included in the national medical insurance drug list every year | Source: CCTV News

Therefore, many people have the impression that the concept of rare diseases is both familiar and unfamiliar: rare diseases don’t seem so "rare", it seems difficult to treat them, and there don’t seem to be so many experts studying rare diseases …

But these superficial impressions are not enough to describe the whole picture of rare diseases.

What is a rare disease? Really "rare"?

In fact, different countries have different definitions of rare diseases. For example, the United States generally defines it as a disease with fewer than 200,000 people in China (that is, about 1 in 1,500), while the prevalence rate in Europe is less than 1 in 2,000.

According to China’s "Research Report on the Definition of Rare Diseases in China 2021", the definition of rare diseases in China is: "Diseases with neonatal morbidity less than 1/ 10,000, morbidity less than 1/ 10,000, and patients less than 140,000 are classified as rare diseases". The main reason is that China has a large population base. If the definition is too loose, the pressure on drug research and development and medical insurance will be too great.

Taking Europe as an example, different countries have different definitions of rare diseases, which often need to be considered according to factors such as population, drug research and development (the unit is every 100,000 people) | Source: Chung C C Y, et al. 2022.

You may be curious: since the prevalence rate is one thousandth or one thousandth, why do you say that it may be too loose to put pressure on the medical system? That’s because the concept of rare diseases is actually a collection of thousands of diseases, or collectively.

According to incomplete statistics, the number of known rare diseases is about 6000-8000. Although the prevalence rate is not all 1/2000, this figure is still very scary-according to the statistical estimation of the incidence rate of 3585 rare diseases, there are about 263-446 million people suffering from various rare diseases all over the world.

This is why, although it is called a rare disease, this group is not "rare" at all.

What does it mean to have a rare disease?

What does it mean to get this rare disease with a probability of one thousandth? Will it become a rare object that is taken care of by everyone like the stars holding the moon?

At least at present, most patients with rare diseases are not so lucky.

First of all, you have to diagnose what disease you are.

But in fact, the diagnosis of rare diseases is very difficult because of limited medical resources and imperfect medical knowledge. About half of the patients with rare diseases in the world still don’t know what disease they have, and the remaining half still face problems such as delayed diagnosis, wrong diagnosis, no treatment plan and unattended care.

What does this mean? If there is a rare patient in Europe, Xiao A, who suddenly has an attack, there is a 25% possibility that Xiao A will not know what disease he has until five years later. In 40% cases, different doctors will give Xiao A different diagnosis and different treatment schemes, and most of these treatment schemes are not helpful to Xiao A because of misdiagnosis.

However, under this wave of operation, Xiao A may have spent a lot of money to cure the disease.

"Layer-by-layer Screening" of Rare Diseases in Europe from Diagnosis to Treatment

In China, however, the shortage of medical resources will only make these ratios higher.

Suppose Xiao A was lucky enough to get an accurate diagnosis in just one year. At this time, the doctor turned over a long list of rare diseases and told Xiao A with regret that there was no medicine for your disease. Because now more than 90% of rare diseases have no good treatment.

This is also the reason why it was mentioned at the beginning that two years ago, the father could only develop drugs to treat his son himself.

As a result, Xiao A will fall into long-term hospitalization or drug treatment, not only can barely maintain his life, but also bear the sky-high medical expenses for life-for example, patients with cystic fibrosis need about 280-1.9 million euros in medical expenses for a lifetime.

Let’s assume that Xiao A is super lucky. Not only is he diagnosed quickly, but he also finds that this rare disease has a very effective orphan drug (rare disease is also called "orphan disease" because the patient is rare, just like "orphan"). As a result, ta may be shocked when he looks at the drug price: it is reported that the average price of rare disease drugs used by each patient is 4.8 times that of other diseases.

You can do a "simple math problem": in 2014, the development of a new drug in China will cost about $1.2 billion, and to maintain the research and development of the whole pharmaceutical industry, it is required that the sales volume should be at least $15 billion. According to the maximum subsidy of 300,000 RMB (about 50,000 US dollars) provided by medical insurance, at least 300,000 patients are needed-and a rare disease is defined as a disease with less than 140,000 patients. Then it requires higher pricing, so that drug researchers and the whole industry can "return to the original".

In other words, patients with rare diseases have to pay more for treatment than other patients.

What does it mean to study rare diseases?

But why are drugs for rare diseases so expensive? Are biomedical companies all black-hearted enterprises? In fact, it is not only patients, but also researchers of rare diseases.

However, the research on rare diseases in China is on the rise, even catching up with common diseases. The above figure shows the number of published research articles, and the following figure shows the number of clinical trials | Source: Yang L, et al.2015.

Suppose researcher Xiao B wants to study a rare disease. The first question Xiao B faces is: Where is my research object?

Although the definition of rare diseases is less than 140,000 people, it sounds like a large number, but in fact only a small number of patients will go to the hospital, and they are scattered in hospitals all over the country.

Not to mention finding a needle in a haystack, it should be as difficult as finding a needle in a swimming pool.

Let’s continue to assume that Xiao B is lucky enough to collect information about dozens of patients with rare diseases in several hospitals and prepare for research. At this time, the question comes again-where does the research funding come from? Rare diseases are mostly genetic diseases, and the study of rare diseases requires gene sequencing, data analysis, animal experiments and so on, which require no less funds than ordinary diseases.

However, from the simple relationship between supply and demand, patients with more common diseases often get more financial support; However, there are more than 5,000 rare diseases with different pathogenesis, so much research funds are available, and what researchers can get is often a drop in the bucket.

From diagnosis to research and development of rare diseases, every step is money, especially when ordinary sequencing (exon sequencing, ES) is ineffective, it is more complicated for researchers to judge the difficulty and exploration direction of rare diseases | Source: Marwaha S, et al. 2022.

However, assuming that Xiao B is lucky, he just applied to the National Natural Science Foundation of China, which has started to increase funding for research on rare diseases in recent years, and got a lot of research funds. Xiao B intends to do a big job to develop an effective drug for this rare disease and solve this rare disease once and for all!

So Xiao B collected patient information, sequenced to find rare disease targets, and began to screen different drugs;

After discovering hundreds of drugs that may be useful, carry out cell experiments and animal experiments;

Finally, five drugs may be effective, so they went to clinical trials;

After the first phase, the second phase and the third phase of the clinic, I was particularly lucky that a drug was proved to be effective;

Start the long drug approval and enter the fourth phase of clinical practice;

Finally, the drug was put into use.

So more than ten years have passed.

Process of new drug research and development | Source: Shanghai Institute of Pharmacology, China Academy of Sciences

In addition, the results brought by the small sample size of patients are unreliable, the experimental design is difficult, and the treatment is not necessarily extensive and effective, which are puzzling the researchers of rare diseases.

It can be seen that it is a thankless thing for researchers to study rare diseases and develop related new drugs.

We can’t ignore it just because it’s "rare"

However, we can’t ignore hundreds of millions of patients with rare diseases because rare diseases are rare, or because research is "thankless".

For patients, governments all over the world have gradually realized the importance of rare diseases, and have increased investment in relevant medical insurance policies, so that more and more patients can get the best treatment at acceptable prices. There was also a hot search for high-priced drug negotiations in the previous two years.

By the end of this year, more than 50 kinds of 75 kinds of drugs for rare diseases that have been approved for listing in China have been included in the medical insurance drug list.

The status quo of rare disease drugs included in medical insurance | Source: Comprehensive report on rare diseases

For the drug research of rare diseases, different countries often support the development of rare diseases drugs from the aspects of research and development funds, drug approval cycle, drug tax relief and so on. In recent years, China has also improved the laws and regulations in this area to better support the research of rare diseases in China.

From the end of last century, governments and research institutions in various countries gradually realized that rare diseases are not rare, and they also deserve public attention. From diagnosis to treatment, from research to drugs, there are more and more different supports, but in the face of 300 million patients and thousands of diseases, the progress now is far from enough.

As a trivial biological science popularization person, we also hope to make a contribution in this respect. Now that China has listed 207 rare diseases, we will try to introduce these "orphan diseases" in simple and easy-to-understand language, which you may have never heard of.

I believe that as long as everyone knows something, orphan disease will no longer be lonely.

References:

? Chung C C Y, Hong Kong Genome Project, Chu A T W, et al. Rare disease emerging as a global public health priority[J]. Frontiers in public health, 2022, 10: 1028545.

The Third Multidisciplinary Expert Seminar on the Definition of Rare Diseases/Orphans in China, Research Report on the Definition of Rare Diseases in China 2021.

Comprehensive report on lilac orchard and rare diseases

? Ferreira C R. The burden of rare diseases[J]. American journal of medical genetics Part A, 2019, 179(6): 885-892.

? Yang L, Su C, Lee A M, et al. Focusing on rare diseases in China: are we there yet? [J]. Orphanet journal of rare diseases, 2015, 10(1): 1-2.

? Griggs R C, Batshaw M, Dunkle M, et al. Clinical research for rare disease: opportunities, challenges, and solutions[J]. Molecular genetics and metabolism, 2009, 96(1): 20-26.

Read the original text

　　On August 31, 2014, the 10th meeting of the 12th the NPC Standing Committee adopted the following amendments to the Government Procurement Law of People’s Republic of China (PRC):

　　(a) in the first paragraph of article nineteenth, "qualified by the relevant departments of the State Council or the relevant departments of the provincial people’s government" is amended as "outside the centralized procurement institution".

　　(two) by deleting the third paragraph of article seventy-first.　

　　(three) the "cancellation of its qualification for relevant business according to law" in Article 78 is amended as "prohibiting it from acting as an agent for government procurement business within one to three years".　

　　Attachment: Revised Government Procurement Law of People’s Republic of China (PRC);　

order of the president of the people’s republic of china　

No.68　

　　The Government Procurement Law of People’s Republic of China (PRC) was adopted by the 28th meeting of the 9th the NPC Standing Committee in People’s Republic of China (PRC) on June 29th, 2002, and is hereby promulgated and shall come into force as of January 1st, 2003.

Jiang Zemin, President of People’s Republic of China (PRC)

June 29, 2002

People’s Republic of China (PRC) government procurement law　

Adopted at the 28th meeting of the 9th the NPC Standing Committee on June 29th, 2002.

　　Chapter I General Provisions　

　　Article 1 This Law is formulated for the purpose of regulating government procurement, improving the efficiency in the use of government procurement funds, safeguarding national interests and social public interests, protecting the legitimate rights and interests of parties involved in government procurement, and promoting the building of a clean government.

　　Article 2 This Law shall apply to government procurement within the territory of People’s Republic of China (PRC).

　　The term "government procurement" as mentioned in this Law refers to the use of financial funds by state organs, institutions and organizations at all levels to purchase goods, projects and services within the centralized procurement catalogue formulated according to law or above the procurement quota standard.

　　The catalogue of centralized government procurement and the standard of procurement quota shall be formulated in accordance with the authority prescribed in this Law.

　　The term "procurement" as mentioned in this Law refers to the behavior of obtaining goods, projects and services for compensation by contract, including purchase, lease, entrustment and employment.

　　"Goods" as mentioned in this Law refers to articles in various forms and types, including raw materials, fuels, equipment and products.

　　The term "project" as mentioned in this Law refers to construction projects, including new construction, reconstruction, expansion, decoration, demolition and repair of buildings and structures.

　　The term "services" as mentioned in this Law refers to other government procurement objects except goods and projects.

　　Article 3 Government procurement shall follow the principles of openness and transparency, fair competition, impartiality and good faith.

　　Article 4 Where government procurement projects are subject to bidding, the bidding law shall apply.

　　Article 5 No unit or individual may, in any way, obstruct or restrict suppliers’ free access to the government procurement market in their own regions and industries.

　　Article 6 Government procurement shall be carried out in strict accordance with the approved budget.

　　Article 7 Government procurement shall combine centralized procurement with decentralized procurement. The scope of centralized procurement is determined by the centralized procurement catalogue published by the people’s governments at or above the provincial level.

　　The centralized procurement catalogue of government procurement projects under the central budget is determined and published by the State Council; The centralized procurement catalogue of government procurement projects belonging to local budgets shall be determined and published by the people’s governments of provinces, autonomous regions and municipalities directly under the Central Government or their authorized institutions.

　　Government procurement projects included in the centralized procurement catalogue shall be subject to centralized procurement.

　　Eighth government procurement quota standards, belonging to the central budget of government procurement projects, determined and promulgated by the State Council; Government procurement projects belonging to local budgets shall be determined and announced by the people’s governments of provinces, autonomous regions and municipalities directly under the Central Government or their authorized institutions.

　　Article 9 Government procurement should help to achieve the national economic and social development policy objectives, including protecting the environment, supporting underdeveloped areas and ethnic minority areas, and promoting the development of small and medium-sized enterprises.

　　Tenth government procurement should purchase domestic goods, projects and services. Except for one of the following circumstances:

　　(a) the goods, projects or services to be purchased cannot be obtained within the territory of China or cannot be obtained on reasonable commercial terms;

　　(2) Purchasing for use outside China;

　　(3) Other laws and administrative regulations provide otherwise.

　　The definition of domestic goods, projects and services mentioned in the preceding paragraph shall be implemented in accordance with the relevant provisions of the State Council.

　　Eleventh government procurement information should be released to the public in a timely manner in the media designated by the government procurement supervision and management department, except those involving commercial secrets.

　　Twelfth in government procurement activities, procurement personnel and related personnel have an interest in suppliers, must be avoided. Suppliers may apply for withdrawal if they think that the procurement personnel and related personnel have interests with other suppliers.

　　The relevant personnel mentioned in the preceding paragraph include the members of the bid evaluation committee in bidding procurement, the members of the negotiation team in competitive negotiation procurement, and the members of the inquiry team in inquiry procurement.

　　Thirteenth financial departments of the people’s governments at all levels are responsible for the supervision and management of government procurement, and perform their duties of supervision and management of government procurement activities according to law.

　　Other relevant departments of the people’s governments at all levels shall perform supervision and management duties related to government procurement activities according to law.

　　Chapter II Parties to Government Procurement　

　　Article 14 The parties to government procurement refer to all kinds of subjects who enjoy rights and assume obligations in government procurement activities, including purchasers, suppliers and procurement agencies.

　　Fifteenth purchasers refer to state organs, institutions and organizations that conduct government procurement according to law.

　　Article 16 The centralized procurement agency is a procurement agency. The people’s governments at or above the level of cities and autonomous prefectures with districts shall set up centralized procurement institutions according to the needs of organizing centralized procurement of government procurement projects at the corresponding level.

　　Centralized procurement institutions are non-profit legal persons, and handle procurement matters according to the entrustment of purchasers.

　　Seventeenth centralized procurement institutions to carry out government procurement activities, should meet the requirements of the purchase price is lower than the average market price, higher procurement efficiency, excellent procurement quality and good service.

　　Eighteenth purchasers of government procurement projects included in the centralized procurement catalogue must entrust centralized procurement agencies to purchase; Government procurement projects that are not included in the centralized procurement catalogue can be purchased by themselves, or they can entrust centralized procurement institutions to purchase on their behalf within the scope entrusted.

　　If it is included in the centralized procurement catalogue and belongs to the general government procurement project, it shall entrust a centralized procurement agency to purchase it; Projects that belong to this department and have special requirements in this system shall be subject to centralized procurement by departments; Belonging to the project with special requirements of the unit,

　　Approved by the people’s governments at or above the provincial level, they can purchase on their own.

　　Article 19 A purchaser may entrust a procurement agency other than a centralized procurement agency to handle government procurement matters within the scope of entrustment.

　　The purchaser has the right to choose the procurement agency by himself, and no unit or individual may designate the procurement agency for the purchaser in any way.

　　Article 20 Where a purchaser entrusts a procurement agency to handle procurement matters according to law, the purchaser shall sign an entrustment agreement with the procurement agency to determine the entrusted matters according to law and stipulate the rights and obligations of both parties.

　　Article 21 A supplier is a legal person, other organization or natural person who provides goods, projects or services to the purchaser.

　　Twenty-second suppliers to participate in government procurement activities shall meet the following conditions:

　　(1) Having the ability to bear civil liability independently;

　　(2) Having a good business reputation and a sound financial accounting system;

　　(3) Having the necessary equipment and professional technical ability to perform the contract;

　　(4) Having a good record of paying taxes and social security funds according to law;

　　(five) in the three years before participating in government procurement activities, there is no major illegal record in business activities;

　　(6) Other conditions stipulated by laws and administrative regulations.

　　The purchaser may, according to the special requirements of the procurement project, stipulate the specific conditions of the supplier, but shall not discriminate or discriminate against the supplier under unreasonable conditions.

　　Article 23 A purchaser may require suppliers participating in government procurement to provide relevant qualification certificates and performance information, and examine the qualifications of suppliers according to the supplier conditions stipulated in this Law and the specific requirements of procurement projects for suppliers.

　　Twenty-fourth more than two natural persons, legal persons or other organizations can form a consortium to participate in government procurement as a supplier.

　　Where government procurement is conducted in the form of a consortium, all suppliers participating in the consortium shall meet the conditions stipulated in Article 22 of this Law, and shall submit a joint agreement to the purchaser, stating the work and obligations undertaken by all parties to the consortium. The parties to the consortium shall jointly sign a procurement contract with the purchaser and bear joint and several liabilities to the purchaser for the matters stipulated in the procurement contract.

　　Twenty-fifth parties to government procurement shall not collude with each other to harm the national interests, social public interests and the legitimate rights and interests of other parties; Other suppliers shall not be excluded from competition by any means.

　　The supplier shall not bribe the purchaser, the procurement agency, the members of the bid evaluation committee, the members of the competitive negotiation team and the members of the inquiry team, or take other improper means to win the bid or clinch a deal.

　　A procurement agency shall not seek illegal interests by bribing the purchaser or by other improper means.

　　Chapter III Methods of Government Procurement　

　　Twenty-sixth government procurement adopts the following methods:

　　(a) public bidding;

　　(2) Inviting tenders;

　　(3) Competitive negotiation;

　　(4) Single-source procurement;

　　(5) Inquiry;

　　(six) other procurement methods identified by the procurement supervision and management department of the State Council Municipal Government.

　　Public bidding should be the main procurement method of government procurement.

　　Twenty-seventh procurement of goods or services should be open tender, the specific amount of the standard, which belongs to the central budget of government procurement projects, by the the State Council; Government procurement projects belonging to local budgets shall be stipulated by the people’s governments of provinces, autonomous regions and municipalities directly under the Central Government; If it is necessary to adopt procurement methods other than public bidding due to special circumstances, it shall obtain the approval of the procurement supervision and administration department of the people’s government at or above the city or autonomous prefecture with districts before the start of procurement activities.

　　Article 28 A purchaser shall not break up the goods or services that should be purchased by public bidding or evade public bidding in any other way.

　　Article 29 Goods or services that meet any of the following circumstances may be purchased by inviting tenders in accordance with this Law:

　　(1) It is special and can only be purchased from a limited range of suppliers;

　　(two) the cost of public bidding accounts for a large proportion of the total value of government procurement projects.

　　Article 30 Goods or services that meet any of the following circumstances may be purchased by competitive negotiation in accordance with this Law:

　　(a) after the tender, there is no supplier to bid, or there is no qualified target, or the new tender cannot be established;

　　(two) the technology is complex or special, and it is impossible to determine the detailed specifications or specific requirements;

　　(three) the time required for bidding can not meet the urgent needs of users;

　　(four) the total price can not be calculated in advance.

　　Article 31 Goods or services that meet any of the following circumstances may be purchased by single source in accordance with this Law:

　　(a) can only be purchased from a sole supplier;

　　(2) Unable to purchase from other suppliers due to unforeseen emergencies;

　　(3) It is necessary to ensure the consistency of the original procurement items or the requirements of supporting services, and it is necessary to continue to purchase from the original suppliers, and the total amount of additional funds does not exceed 10% of the original contract purchase amount.

　　Article 32 Government procurement projects with uniform goods specifications and standards, sufficient spot supply and small price changes may be purchased by inquiry in accordance with this Law.

　　Chapter IV Government Procurement Procedures　

　　Thirty-third departments responsible for the preparation of departmental budgets shall, when preparing departmental budgets for the next fiscal year, list the projects and capital budgets of government procurement in this fiscal year and report them to the financial department at the same level for summary. The examination and approval of departmental budgets shall be conducted according to the budget management authority and procedures.

　　Article 34 Where goods or services are purchased by inviting public bidding, the purchaser shall select more than three suppliers from the suppliers who meet the corresponding qualification conditions by random method, and issue an invitation to bid to them.

　　Article 35 Where goods and services are purchased by tender, it shall not be less than 20 days from the date when the tender documents are issued to the deadline when the bidders submit their tender documents.

　　Thirty-sixth in the bidding, one of the following circumstances, should be abolished:

　　(1) There are less than three suppliers who meet the professional requirements or make substantial responses to the bidding documents;

　　(two) there are violations of laws and regulations that affect the procurement justice;

　　(three) the bidders’ quotations all exceed the procurement budget, and the purchaser cannot pay;

　　(four) due to major changes, the procurement task is cancelled.

　　After the bid is cancelled, the purchaser shall notify all bidders of the reasons for the cancellation.

　　Thirty-seventh after the cancellation of the tender, except for the cancellation of the procurement task, the tender should be re-organized; If it is necessary to adopt other procurement methods, it shall be approved by the procurement supervision and administration department of the people’s government at or above the city or autonomous prefecture with districts or the relevant government departments before the start of procurement activities.

　　Thirty-eighth procurement by competitive negotiation shall follow the following procedures:

　　(a) the establishment of a negotiating team. The negotiating team consists of representatives of the purchaser and relevant experts in an odd number of more than three, of which the number of experts shall not be less than two thirds of the total number of members.

　　(2) Formulating negotiation documents. The negotiation documents shall specify the negotiation procedures, contents, terms of the draft contract and the criteria for evaluating the transaction.

　　(three) to determine the list of suppliers invited to participate in the negotiations. The negotiating team shall determine at least three suppliers from the list of suppliers who meet the corresponding qualifications to participate in the negotiation and provide them with negotiation documents.

　　(4) negotiation. All members of the negotiating team concentrate on negotiating with a single supplier. During the negotiation, neither party shall disclose the technical data, prices and other information of other suppliers related to the negotiation. If there are substantial changes in the negotiation documents, the negotiating team shall notify all suppliers participating in the negotiation in writing.

　　(five) to determine the supplier. After the negotiation, the negotiating team shall require all the suppliers participating in the negotiation to make the final quotation within the specified time, and the purchaser shall determine the successful supplier from among the successful candidates proposed by the negotiating team according to the principle of meeting the procurement demand, equal quality and service and the lowest quotation, and notify all the unsuccessful suppliers participating in the negotiation of the results.

　　Article 39 In the case of single-source procurement, the purchaser and the supplier shall follow the principles stipulated in this Law and conduct the procurement on the basis of ensuring the quality of the purchased items and reasonable prices agreed by both parties.

　　Fortieth procurement by inquiry shall follow the following procedures:

　　(a) the establishment of inquiry team. The inquiry team consists of representatives of the purchaser and relevant experts in an odd number of more than three, of which the number of experts shall not be less than two thirds of the total number of members. The inquiry team shall stipulate the price composition of the procurement project and the criteria for evaluating the transaction.

　　(two) to determine the list of suppliers to be inquired. According to the purchase demand, the inquiry team determines at least three suppliers from the list of suppliers who meet the corresponding qualifications, and sends them an inquiry notice for quotation.

　　(3) Inquiry. The inquiry team requires the inquired supplier to quote a price that cannot be changed at one time.

　　(4) Determine the supplier of the transaction. The purchaser determines the clinched supplier according to the principle of meeting the purchasing demand, equal quality and service and lowest quotation, and informs all the suppliers who have not clinched the transaction after being inquired about the result.

　　Article 41 The purchaser or the procurement agency entrusted by him shall organize the acceptance of the supplier’s performance. Large-scale or complex government procurement projects shall invite quality inspection institutions recognized by the state to participate in the acceptance work. Members of the acceptance party shall sign the acceptance letter and bear corresponding legal responsibilities.

　　Forty-second purchasers and procurement agencies shall properly keep the procurement documents of each procurement activity of government procurement projects, and shall not forge, alter, conceal or destroy them. The storage period of procurement documents is at least fifteen years from the date of the end of procurement.

　　Procurement documents include records of procurement activities, procurement budget, bidding documents, bidding documents, bid evaluation standards, evaluation reports, calibration documents, contract texts, acceptance certificates, query replies, complaint handling decisions and other relevant documents and materials.

　　The record of procurement activities shall at least include the following contents:

　　(a) the category and name of the procurement project;

　　(2) The budget, capital composition and contract price of the procurement project;

　　(three) the procurement method, the procurement method other than public bidding, shall specify the reasons;

　　(4) Conditions and reasons for inviting and selecting suppliers;

　　(five) the evaluation criteria and the reasons for determining the winning bidder;

　　(six) the reasons for the abolition of the target;

　　(seven) the corresponding records of purchasing methods other than bidding.

　　Chapter V Government Procurement Contracts　

　　Article 43 The contract law shall apply to government procurement contracts. The rights and obligations between the purchaser and the supplier shall be agreed by contract in accordance with the principle of equality and voluntariness.

　　A purchaser may entrust a procurement agency to sign government procurement contracts with suppliers on its behalf. Where a contract is signed by a procurement agency in the name of the purchaser, the power of attorney of the purchaser shall be submitted as an annex to the contract.

　　Article 44 A government procurement contract shall be in written form.

　　Forty-fifth the State Council municipal government procurement supervision and management department shall, in conjunction with the relevant departments of the State Council, stipulate the terms that the government procurement contract must have.

　　Article 46 The purchaser and the supplier who won the bid and clinched the deal shall, within 30 days from the date of issuance of the notice of winning the bid and clinched the deal, sign the government procurement contract according to the matters specified in the procurement documents.

　　The bid-winning and transaction notice has legal effect on both the purchaser and the bid-winning and transaction supplier. If, after the notice of bid winning and transaction is issued, the purchaser changes the result of bid winning and transaction, or if the supplier of bid winning and transaction abandons the project of bid winning and transaction, it shall bear legal liability according to law.

　　Article 47 Within seven working days from the date of signing the procurement contract for government procurement projects, the purchaser shall submit a copy of the contract to the government procurement supervision and management department and relevant departments at the same level for the record.

　　Forty-eighth with the consent of the purchaser, the successful bidder and the successful supplier may perform the contract by subcontracting according to law.

　　If the government procurement contract is subcontracted, the successful bidder and the successful bidder shall be responsible to the purchaser for the procurement project and the subcontracted project, and the subcontracted supplier shall be responsible for the subcontracted project.

　　Article 49 In the performance of a government procurement contract, if the purchaser needs to add the same goods, projects or services as the subject matter of the contract, he may negotiate with the supplier to sign a supplementary contract without changing other terms of the contract, but the purchase amount of all supplementary contracts shall not exceed 10% of the original contract purchase amount.

　　Article 50 The parties to a government procurement contract shall not alter, suspend or terminate the contract without authorization.

　　If the continued performance of the government procurement contract will harm the national interests and social public interests, both parties shall modify, suspend or terminate the contract. The party at fault shall be liable for compensation. If both parties are at fault, they shall bear corresponding responsibilities.

　　Chapter VI Queries and Complaints　

　　Article 51 If a supplier has questions about government procurement activities, he may ask the purchaser, and the purchaser shall give a timely reply, but the contents of the reply shall not involve commercial secrets.

　　Article 52 If a supplier believes that his rights and interests have been harmed by the procurement documents, procurement process and the results of winning the bid and closing the transaction, he may, within seven working days from the date when he knows or should know that his rights and interests have been harmed, raise a written question to the purchaser.

　　Article 53 The purchaser shall give a reply within seven working days after receiving the written query from the supplier, and notify the questioned supplier and other relevant suppliers in writing, but the content of the reply shall not involve trade secrets.

　　Article 54 If the purchaser entrusts a procurement agency to purchase, the supplier may ask or question the procurement agency, and the procurement agency shall reply to the matters within the scope of the purchaser’s entrustment in accordance with the provisions of Articles 51 and 53 of this Law.

　　Article 55 If a supplier is dissatisfied with the reply of the purchaser or the procurement agency, or the purchaser or the procurement agency fails to make a reply within the specified time, he may complain to the procurement supervision and administration department of the government at the same level within 15 working days after the reply expires.

　　Fifty-sixth government procurement supervision and management departments shall, within thirty working days after receiving the complaint, make a decision on the handling of the complaint, and notify the complainant and the parties concerned in writing.

　　Fifty-seventh government procurement supervision and management departments in handling complaints, according to the specific circumstances, notify the purchaser in writing to suspend procurement activities, but the longest suspension period shall not exceed 30 days.

　　Article 58 If a complainant refuses to accept the decision of the government procurement supervision and administration department to handle the complaint or the government procurement supervision and administration department fails to handle it within the time limit, he may apply for administrative reconsideration or bring an administrative lawsuit to the people’s court according to law.

　　Chapter VII Supervision and Inspection　

　　Fifty-ninth government procurement supervision and management departments should strengthen the supervision and inspection of government procurement activities and centralized procurement institutions.

　　The main contents of supervision and inspection are:

　　(a) the implementation of laws, administrative regulations and rules on government procurement;

　　(two) the scope of procurement, procurement methods and implementation of procurement procedures;

　　(three) the professional quality and professional skills of government procurement personnel.

　　Sixtieth government procurement supervision and management departments shall not set up centralized procurement institutions, and shall not participate in the procurement activities of government procurement projects.

　　There shall be no subordinate relationship or other interest relationship between the procurement agency and the administrative organ.

　　Article 61 A centralized procurement institution shall establish and improve its internal supervision and management system. The decision-making and execution procedures of procurement activities should be clear, and supervise and restrict each other. The responsibilities and authorities of the personnel handling procurement and those responsible for the examination and acceptance of procurement contracts shall be clear and separate from each other.

　　Article 62 The procurement personnel of centralized procurement institutions shall have relevant professional qualities and skills, and meet the requirements for professional posts as stipulated by the government procurement supervision and administration department.

　　Centralized procurement institutions should strengthen education and training for their staff; Regularly assess the professional level, work performance and professional ethics of procurement personnel. Procurement personnel who fail to pass the examination shall not continue to serve.

　　Article 63 The procurement standards for government procurement projects shall be made public.

　　Where the procurement method specified in this Law is adopted, the purchaser shall publish the procurement results after the procurement activities are completed.

　　Article 64 A purchaser must conduct procurement in accordance with the procurement methods and procedures stipulated in this Law.

　　No unit or individual may, in violation of the provisions of this law, require purchasers or procurement staff to purchase from suppliers designated by them.

　　Sixty-fifth government procurement supervision and management departments shall inspect the procurement activities of government procurement projects, and the parties to government procurement shall truthfully reflect the situation and provide relevant materials.

　　Article 66 The government procurement supervision and management department shall assess the purchase price, fund-saving effect, service quality, reputation status and whether there are any illegal acts of centralized procurement institutions, and regularly publish the assessment results truthfully.

　　Article 67 The relevant government departments responsible for administrative supervision of government procurement in accordance with the provisions of laws and administrative regulations shall strengthen supervision of government procurement activities in accordance with their division of responsibilities.

　　Article 68 Audit institutions shall supervise government procurement through auditing. The supervision and administration department of government procurement and the parties involved in government procurement shall accept the audit supervision of audit institutions.

　　Article 69 Supervisory organs shall strengthen supervision over state organs, state civil servants and other personnel appointed by state administrative organs who participate in government procurement activities.

　　Article 70 Any unit or individual shall have the right to accuse and expose illegal acts in government procurement activities, and relevant departments and organs shall promptly deal with them according to their respective functions and duties.

　　Chapter VIII Legal Liability　

　　Article 71 If a purchaser or a procurement agency is under any of the following circumstances, it shall be ordered to make corrections within a time limit, given a warning, and may also be fined. The directly responsible person in charge and other directly responsible personnel shall be punished by the administrative department or the relevant authorities and notified:

　　(1) Purchasing by other means without authorization by means of public bidding;

　　(2) raising the procurement standards without authorization;

　　(3) Differentiating or discriminating against suppliers under unreasonable conditions;

　　(four) in the process of bidding and purchasing negotiations with bidders;

　　(5) Failing to sign a procurement contract with the supplier who won the bid or clinched the deal after the notice of winning the bid or clinched the deal is issued;

　　(six) refusing the relevant departments to carry out supervision and inspection according to law.

　　Article 72 If a purchaser, a procurement agency and its staff are under any of the following circumstances, which constitutes a crime, criminal responsibility shall be investigated according to law; If the case does not constitute a crime, it shall be fined, and if there are illegal gains, the illegal gains shall be confiscated. If it belongs to the staff of state organs, it shall be given administrative sanctions according to law:

　　(1) Malicious collusion with suppliers or procurement agencies;

　　(2) Accepting bribes or obtaining other illegitimate interests in the procurement process;

　　(three) providing false information in the supervision and inspection carried out by the relevant departments according to law;

　　(4) disclosing the pre-tender estimate before the bid opening.

　　Article 73 If one of the first two illegal acts affects or may affect the bid-winning and transaction results, it shall be dealt with separately according to the following circumstances:

　　(1) If the supplier who won the bid or clinched the deal is not determined, the procurement activities shall be terminated;

　　(2) If the supplier who won the bid and clinched the deal has been determined but the procurement contract has not been fulfilled, the contract shall be cancelled and the supplier who won the bid and clinched the deal shall be determined separately from the qualified candidates;

　　(3) If the procurement contract has been performed and losses are caused to the purchaser and supplier, the responsible person shall be liable for compensation.

　　Article 74 Where a purchaser fails to entrust a centralized procurement agency to carry out centralized procurement for government procurement projects that should be subject to centralized procurement, the government procurement supervision and administration department shall order it to make corrections; Refuses to correct, stop paying the funds according to the budget, and be punished by the superior administrative department or the relevant authorities according to law.

　　Article 75 If a purchaser fails to publish the procurement standards and procurement results of government procurement projects according to law, it shall be ordered to make corrections, and the directly responsible person in charge shall be punished according to law.

　　Article 76 Where a purchaser or procurement agency conceals or destroys the procurement documents that should be kept or forges or alters the procurement documents in violation of the provisions of this Law, the government procurement supervision and administration department shall impose a fine of not less than 20,000 yuan but not more than 100,000 yuan, and the directly responsible person in charge and other directly responsible personnel shall be punished according to law; If a crime is constituted, criminal responsibility shall be investigated according to law.

　　Article 77 In any of the following circumstances, a supplier shall be fined from 0.5% to 0.10% of the purchase amount, listed in the list of bad behavior records, and prohibited from participating in government procurement activities for one to three years. If there are illegal gains, the illegal gains shall be confiscated, and if the circumstances are serious, the business license shall be revoked by the administrative department for industry and commerce; If the case constitutes a crime, criminal responsibility shall be investigated according to law:

　　(a) providing false materials for winning the bid and closing the deal;

　　(2) Defaming or crowding out other suppliers by improper means;

　　(3) Malicious collusion with purchasers, other suppliers or procurement agencies;

　　(4) Bribing bribes or providing other illegitimate interests to purchasers or procurement agencies;

　　(five) negotiation with the purchaser in the process of bidding and purchasing;

　　(six) refusing the supervision and inspection of the relevant departments or providing false information.

　　If the supplier is under any of the circumstances mentioned in Items (1) to (5) of the preceding paragraph, the bid winning and transaction is invalid.

　　Article 78 If a procurement agency commits illegal acts in acting as an agent for government procurement, it shall be fined in accordance with the relevant laws and regulations, and may be prohibited from acting as an agent for government procurement for one to three years. If the case constitutes a crime, criminal responsibility shall be investigated according to law.

　　Article 79 If a party to government procurement commits one of the illegal acts in Articles 71, 72 and 77 of this Law, causing losses to others, he shall bear civil liability in accordance with the relevant civil laws.

　　Article 80 Any staff member of the government procurement supervision and administration department who abuses his power, neglects his duty or engages in malpractices for personal gain in violation of the provisions of this Law in the course of supervision and inspection shall be given administrative sanctions according to law; If a crime is constituted, criminal responsibility shall be investigated according to law.

　　Article 81 If the government procurement supervision and management department fails to deal with the supplier’s complaints within the time limit, it shall give administrative sanctions to the directly responsible person in charge and other directly responsible personnel.

　　Article 82 If the government procurement supervision and management department makes false statements in the performance evaluation of centralized procurement institutions, conceals the real situation, or fails to make regular evaluation and publish the evaluation results, it shall promptly correct it, and its superior organ or supervisory organ shall notify its responsible person, and the person directly responsible shall be given administrative sanctions according to law.

　　Centralized procurement institutions in the assessment of government procurement supervision and management departments, false performance, conceal the real situation, impose a fine of 20 thousand yuan to 200 thousand yuan, and shall be notified; If the circumstances are serious, it shall be disqualified from purchasing as an agent.

　　Eighty-third any unit or individual that obstructs or restricts suppliers from entering the government procurement market in their own region or industry shall be ordered to make corrections within a time limit; Refuses to correct, the unit or individual shall be punished by the superior administrative department or the relevant authorities.

　　Chapter IX Supplementary Provisions　

　　Article 84 If the agreement reached between the lender and the fund provider and the Chinese side provides otherwise on the specific conditions of government procurement with loans from international organizations and foreign governments, such provisions may be applied, provided that the national interests and social public interests are not harmed.

　　Article 85 This Law is not applicable to urgent procurement due to serious natural disasters and other force majeure events and procurement involving national security and secrets.

　　Article 86 Military procurement laws and regulations shall be formulated separately by the Central Military Commission (CMC).

　　Article 87 The specific steps and measures for the implementation of this Law shall be formulated by the State Council.

　　Article 88 This Law shall come into force as of January 1, 2003.